| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 GBF1 SRGAP1 HERC2 TBC1D3I TBC1D3K ARAP2 TBC1D3F RGPD2 TBC1D3E ADAP1 TBC1D3 HTR2B TBC1D3L TBC1D3D TBC1D22B SRGAP2 SIPA1 TBC1D3C RGS3 DENND4C GNA13 KNDC1 GPSM1 SPATA13 | 5.42e-08 | 507 | 279 | 25 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 GBF1 SRGAP1 HERC2 TBC1D3I TBC1D3K ARAP2 TBC1D3F RGPD2 TBC1D3E ADAP1 TBC1D3 HTR2B TBC1D3L TBC1D3D TBC1D22B SRGAP2 SIPA1 TBC1D3C RGS3 DENND4C GNA13 KNDC1 GPSM1 SPATA13 | 5.42e-08 | 507 | 279 | 25 | GO:0030695 |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 SRGAP1 TBC1D3I TBC1D3K ARAP2 TBC1D3F RGPD2 TBC1D3E ADAP1 TBC1D3 HTR2B TBC1D3L TBC1D3D TBC1D22B SRGAP2 SIPA1 TBC1D3C RGS3 | 8.53e-08 | 279 | 279 | 18 | GO:0005096 |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 2.70e-06 | 3 | 279 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.10e-05 | 55 | 279 | 7 | GO:0008146 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH10 MYO1D MYO5B VWA8 SMARCAD1 ATP8B1 CLPX LONP1 ATP11A KIF2A ABCC10 HSP90AB3P TTF2 DNAH10 ATG7 DHX37 DDX52 TWNK ATP13A5 G3BP1 SMARCA2 DNAH11 AFG1L | 1.90e-05 | 614 | 279 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 2.64e-05 | 5 | 279 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 4.51e-05 | 15 | 279 | 4 | GO:0034483 | |
| GeneOntologyMolecularFunction | chitinase activity | 5.23e-05 | 6 | 279 | 3 | GO:0004568 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO5B VWA8 SMARCAD1 ATP8B1 CLPX LONP1 ATP11A KIF2A ABCC10 HSP90AB3P DNAH10 DHX37 DDX52 TWNK ATP13A5 G3BP1 DNAH11 AFG1L | 5.27e-05 | 441 | 279 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 7.80e-05 | 74 | 279 | 7 | GO:0016782 | |
| GeneOntologyMolecularFunction | chitin binding | 1.43e-04 | 8 | 279 | 3 | GO:0008061 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 CLPX SRGAP1 GNAS TBC1D3I DMWD TBC1D3K ARAP2 TBC1D3F RGPD2 TBC1D3E ADAP1 TBC1D3 HTR2B TBC1D3L TBC1D3D TBC1D22B SRGAP2 SIPA1 TBC1D3C RGS3 GUCA1C | 1.46e-04 | 656 | 279 | 22 | GO:0008047 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYO5B VWA8 SMARCAD1 ATP8B1 CLPX LONP1 RAB28 ATP11A KIF2A GNAS ABCC10 HSP90AB3P DNAH10 DHX37 DDX52 TWNK ATP13A5 RGS3 G3BP1 RERGL GNA13 RASL11B DNAH11 AFG1L | 2.42e-04 | 775 | 279 | 24 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYO5B VWA8 GARS1 SMARCAD1 ATP8B1 CLPX LONP1 RAB28 ATP11A KIF2A GNAS ABCC10 HSP90AB3P DNAH10 DHX37 DDX52 TWNK ATP13A5 RGS3 G3BP1 RERGL GNA13 RASL11B DNAH11 AFG1L | 3.20e-04 | 839 | 279 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYO5B VWA8 GARS1 SMARCAD1 ATP8B1 CLPX LONP1 RAB28 ATP11A KIF2A GNAS ABCC10 HSP90AB3P DNAH10 DHX37 DDX52 TWNK ATP13A5 RGS3 G3BP1 RERGL GNA13 RASL11B DNAH11 AFG1L | 3.26e-04 | 840 | 279 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYO5B VWA8 GARS1 SMARCAD1 ATP8B1 CLPX LONP1 RAB28 ATP11A KIF2A GNAS ABCC10 HSP90AB3P DNAH10 DHX37 DDX52 TWNK ATP13A5 RGS3 G3BP1 RERGL GNA13 RASL11B DNAH11 AFG1L | 3.26e-04 | 840 | 279 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | heparan sulfate 6-O-sulfotransferase activity | 5.78e-04 | 3 | 279 | 2 | GO:0017095 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 8.72e-04 | 31 | 279 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | glutamate binding | 8.76e-04 | 14 | 279 | 3 | GO:0016595 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.15e-03 | 4 | 279 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.15e-03 | 4 | 279 | 2 | GO:0005219 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.26e-06 | 42 | 275 | 7 | GO:0099560 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3I TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3L TBC1D3D TBC1D22B TBC1D3C EPHA2 | 2.01e-06 | 109 | 275 | 10 | GO:0090630 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | CCR9 RYR2 RYR3 CXCR5 CCR7 HTR2B CASQ2 GRIN2A GRIN2B GRM1 RCAN3 CAMKK2 PPP3R1 P2RX3 MTOR | 3.12e-06 | 266 | 275 | 15 | GO:0019722 |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 4.16e-06 | 70 | 275 | 8 | GO:0030166 | |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 6.00e-06 | 97 | 275 | 9 | GO:0006029 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 1.03e-05 | 38 | 275 | 6 | GO:0000272 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | CCR7 TBC1D3I TBC1D3K ARAP2 TBC1D3F TBC1D3E ADAP1 TBC1D3 TBC1D3L TBC1D3D TBC1D22B SRGAP2 TBC1D3C MTOR EPHA2 GPSM1 | 1.21e-05 | 335 | 275 | 16 | GO:0043087 |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 1.41e-05 | 12 | 275 | 4 | GO:0015015 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | JAML FAT1 PTPRD PTPRF NRXN1 PVR FLRT3 PCDH18 PCDHGA11 PCDHB13 PCDHB12 PTPN23 SLITRK3 TENM4 TENM3 | 2.18e-05 | 313 | 275 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | CCR7 TBC1D3I TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3L TBC1D3D TBC1D22B SRGAP2 TBC1D3C EPHA2 | 2.59e-05 | 244 | 275 | 13 | GO:0043547 |
| GeneOntologyBiologicalProcess | uterus morphogenesis | 4.55e-05 | 6 | 275 | 3 | GO:0061038 | |
| GeneOntologyBiologicalProcess | chitin catabolic process | 4.55e-05 | 6 | 275 | 3 | GO:0006032 | |
| GeneOntologyBiologicalProcess | chitin metabolic process | 4.55e-05 | 6 | 275 | 3 | GO:0006030 | |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 4.94e-05 | 126 | 275 | 9 | GO:0005976 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | HEXA RGPD4 CHIA CHST14 CHIT1 CLTC PYGB PYGL PYGM ALDH1B1 KLB ENOSF1 RGPD2 CHST10 MAN1C1 NDST2 FUOM PPP1CB RPIA OVGP1 CASD1 MTOR | 5.97e-05 | 646 | 275 | 22 | GO:0005975 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 6.09e-05 | 32 | 275 | 5 | GO:0048266 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan metabolic process | 6.42e-05 | 17 | 275 | 4 | GO:0030201 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 7.10e-05 | 132 | 275 | 9 | GO:0006022 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 9.51e-05 | 35 | 275 | 5 | GO:0015012 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | RYR2 RYR3 CCR7 CACNA1A CACNA1E HTR2B CASQ2 GRIN2A GRIN2B PPP3R1 P2RX3 | 1.68e-04 | 217 | 275 | 11 | GO:0097553 |
| GeneOntologyBiologicalProcess | glucosamine-containing compound catabolic process | 1.86e-04 | 9 | 275 | 3 | GO:1901072 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.91e-04 | 63 | 275 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | startle response | 2.06e-04 | 41 | 275 | 5 | GO:0001964 | |
| GeneOntologyCellularComponent | neurofibrillary tangle | 2.26e-05 | 5 | 277 | 3 | GO:0097418 | |
| GeneOntologyCellularComponent | calcium channel complex | 5.14e-05 | 73 | 277 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | BACE1 PICALM NEFM NEFH PTPRD PTPRF NRXN1 FLRT3 AKAP7 SLITRK3 SRGAP2 GRIN2A GRIN2B GRM1 USP6 PPP3R1 P2RX3 SNX1 | 2.30e-04 | 523 | 277 | 18 | GO:0098984 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.31e-04 | 155 | 277 | 9 | GO:0098685 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 2.60e-04 | 67 | 277 | 6 | GO:0098686 | |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 MYO1D MYO5B TRPC5 NAP1L4 BACE1 BRINP1 UPF3B PICALM NEFM NEFH PTPRF NRXN1 GNAS DMWD CACNA1A CACNA1E HTR2B GRIN2B GRM1 P2RX3 G3BP1 MTOR KNDC1 | 3.32e-04 | 835 | 277 | 24 | GO:0043025 |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 3.58e-04 | 26 | 277 | 4 | GO:0099571 | |
| GeneOntologyCellularComponent | ciliary pocket membrane | 5.20e-04 | 3 | 277 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 5.20e-04 | 3 | 277 | 2 | GO:0020016 | |
| Domain | TBC | TBC1D3I TBC1D3K TBC1D3F TBC1D3E TBC1D3L TBC1D3D TBC1D22B TBC1D3C USP6 | 4.09e-08 | 49 | 280 | 9 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3I TBC1D3K TBC1D3F TBC1D3E TBC1D3L TBC1D3D TBC1D22B TBC1D3C USP6 | 8.37e-08 | 53 | 280 | 9 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3I TBC1D3K TBC1D3F TBC1D3E TBC1D3L TBC1D3D TBC1D22B TBC1D3C USP6 | 1.17e-07 | 55 | 280 | 9 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3I TBC1D3K TBC1D3F TBC1D3E TBC1D3L TBC1D3D TBC1D22B TBC1D3C USP6 | 1.17e-07 | 55 | 280 | 9 | PS50086 |
| Domain | Ribosomal_S4e_central_region | 3.33e-06 | 3 | 280 | 3 | IPR013845 | |
| Domain | Ribosomal_S4e_N | 3.33e-06 | 3 | 280 | 3 | IPR013843 | |
| Domain | 40S_S4_C | 3.33e-06 | 3 | 280 | 3 | PF16121 | |
| Domain | Ribosomal_S4e_N_CS | 3.33e-06 | 3 | 280 | 3 | IPR018199 | |
| Domain | Phosphorylase | 3.33e-06 | 3 | 280 | 3 | PF00343 | |
| Domain | Ribosomal_S4e | 3.33e-06 | 3 | 280 | 3 | IPR000876 | |
| Domain | RIBOSOMAL_S4E | 3.33e-06 | 3 | 280 | 3 | PS00528 | |
| Domain | PHOSPHORYLASE | 3.33e-06 | 3 | 280 | 3 | PS00102 | |
| Domain | Ribosomal_S4e_central | 3.33e-06 | 3 | 280 | 3 | PD002667 | |
| Domain | Glycg_phsphrylas | 3.33e-06 | 3 | 280 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 3.33e-06 | 3 | 280 | 3 | IPR000811 | |
| Domain | 40S_S4_C | 3.33e-06 | 3 | 280 | 3 | IPR032277 | |
| Domain | RS4NT | 3.33e-06 | 3 | 280 | 3 | PF08071 | |
| Domain | Ribosomal_S4e | 3.33e-06 | 3 | 280 | 3 | PF00900 | |
| Domain | P-loop_NTPase | MYH10 MYO1D MYO5B VWA8 HS6ST2 SMARCAD1 CLPX EHD3 LONP1 RAB28 NWD2 HS6ST1 EHD1 KIF2A GNAS HS3ST1 ABCC10 TTF2 TPST1 DNAH10 DHX37 DDX52 NDST2 TWNK RERGL GNA13 SMARCA2 RASL11B CTPS1 DNAH11 AFG1L | 4.46e-06 | 848 | 280 | 31 | IPR027417 |
| Domain | Sulfotransferase | 2.23e-05 | 12 | 280 | 4 | IPR005331 | |
| Domain | Sulfotransfer_2 | 2.23e-05 | 12 | 280 | 4 | PF03567 | |
| Domain | - | 3.26e-05 | 5 | 280 | 3 | 3.10.50.10 | |
| Domain | S4 | 3.26e-05 | 5 | 280 | 3 | PS50889 | |
| Domain | S4 | 3.26e-05 | 5 | 280 | 3 | SM00363 | |
| Domain | Chitinase_insertion | 3.26e-05 | 5 | 280 | 3 | IPR029070 | |
| Domain | S4_RNA-bd | 6.45e-05 | 6 | 280 | 3 | IPR002942 | |
| Domain | Glyco_hydro_18_chit_AS | 6.45e-05 | 6 | 280 | 3 | IPR001579 | |
| Domain | Glyco_hydro_18 | 1.12e-04 | 7 | 280 | 3 | PF00704 | |
| Domain | Chitinase_II | 1.12e-04 | 7 | 280 | 3 | IPR011583 | |
| Domain | CHITINASE_18 | 1.12e-04 | 7 | 280 | 3 | PS01095 | |
| Domain | Glyco_hydro18_cat | 1.12e-04 | 7 | 280 | 3 | IPR001223 | |
| Domain | Glyco_18 | 1.12e-04 | 7 | 280 | 3 | SM00636 | |
| Domain | - | VWA8 SMARCAD1 CLPX EHD3 LONP1 RAB28 NWD2 EHD1 GNAS HS3ST1 ABCC10 TTF2 TPST1 DNAH10 DHX37 DDX52 NDST2 TWNK RERGL GNA13 SMARCA2 RASL11B CTPS1 DNAH11 AFG1L | 1.56e-04 | 746 | 280 | 25 | 3.40.50.300 |
| Domain | - | 1.64e-04 | 35 | 280 | 5 | 3.20.20.80 | |
| Domain | ANF_lig-bd_rcpt | 2.15e-04 | 37 | 280 | 5 | IPR001828 | |
| Domain | ANF_receptor | 2.15e-04 | 37 | 280 | 5 | PF01094 | |
| Domain | Memapsin-like | 2.24e-04 | 2 | 280 | 2 | IPR033874 | |
| Domain | MeTrfase_trithorax | 2.24e-04 | 2 | 280 | 2 | IPR016569 | |
| Domain | CBM_14 | 2.24e-04 | 2 | 280 | 2 | PF01607 | |
| Domain | CHIT_BIND_II | 2.24e-04 | 2 | 280 | 2 | PS50940 | |
| Domain | DM15 | 2.24e-04 | 2 | 280 | 2 | IPR006607 | |
| Domain | ChtBD2 | 2.24e-04 | 2 | 280 | 2 | SM00494 | |
| Domain | Chitin-bd_dom | 2.24e-04 | 2 | 280 | 2 | IPR002557 | |
| Domain | BACE | 2.24e-04 | 2 | 280 | 2 | IPR009119 | |
| Domain | DM15 | 2.24e-04 | 2 | 280 | 2 | SM00684 | |
| Domain | - | 2.24e-04 | 2 | 280 | 2 | 2.170.140.10 | |
| Domain | EHD1/EHD3 | 2.24e-04 | 2 | 280 | 2 | IPR029951 | |
| Domain | Glyco_hydro_catalytic_dom | 2.45e-04 | 38 | 280 | 5 | IPR013781 | |
| Domain | Peripla_BP_I | 2.77e-04 | 39 | 280 | 5 | IPR028082 | |
| Domain | KOW | 5.03e-04 | 11 | 280 | 3 | IPR005824 | |
| Domain | KOW | 5.03e-04 | 11 | 280 | 3 | PF00467 | |
| Domain | AT_hook | 6.61e-04 | 27 | 280 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 6.61e-04 | 27 | 280 | 4 | IPR017956 | |
| Domain | Rhs_assc_core | 6.65e-04 | 3 | 280 | 2 | IPR022385 | |
| Domain | AKAP7_NLS | 6.65e-04 | 3 | 280 | 2 | PF10469 | |
| Domain | NMDAR2_C | 6.65e-04 | 3 | 280 | 2 | PF10565 | |
| Domain | Heparan_SO4-6-sulfoTrfase | 6.65e-04 | 3 | 280 | 2 | IPR010635 | |
| Domain | RyR | 6.65e-04 | 3 | 280 | 2 | PF02026 | |
| Domain | Kinase-A_anchor_nucl_local_sig | 6.65e-04 | 3 | 280 | 2 | IPR019510 | |
| Domain | RR_TM4-6 | 6.65e-04 | 3 | 280 | 2 | PF06459 | |
| Domain | Ryan_recept | 6.65e-04 | 3 | 280 | 2 | IPR013333 | |
| Domain | Ryanodine_rcpt | 6.65e-04 | 3 | 280 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 6.65e-04 | 3 | 280 | 2 | IPR009460 | |
| Domain | NMDAR2_C | 6.65e-04 | 3 | 280 | 2 | IPR018884 | |
| Domain | ATPase_dyneun-rel_AAA | 1.07e-03 | 14 | 280 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.07e-03 | 14 | 280 | 3 | PF07728 | |
| Domain | Glycoside_hydrolase_SF | 1.16e-03 | 53 | 280 | 5 | IPR017853 | |
| Domain | Tox-GHH_dom | 1.32e-03 | 4 | 280 | 2 | IPR028916 | |
| Domain | Tox-GHH | 1.32e-03 | 4 | 280 | 2 | PF15636 | |
| Domain | S4 | 1.32e-03 | 4 | 280 | 2 | PF01479 | |
| Domain | Ten_N | 1.32e-03 | 4 | 280 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.32e-03 | 4 | 280 | 2 | PS51361 | |
| Domain | Ten_N | 1.32e-03 | 4 | 280 | 2 | IPR009471 | |
| Domain | Post-SET_dom | 1.62e-03 | 16 | 280 | 3 | IPR003616 | |
| Domain | PostSET | 1.62e-03 | 16 | 280 | 3 | SM00508 | |
| Domain | POST_SET | 1.62e-03 | 16 | 280 | 3 | PS50868 | |
| Domain | ARM-type_fold | CEP104 GBF1 NBEAL1 RYR3 NOP9 PIK3C2A CLTC ZYG11B ARMC9 MTOR AOPEP STAG2 XPO7 | 1.90e-03 | 339 | 280 | 13 | IPR016024 |
| Domain | PTPc | 2.00e-03 | 36 | 280 | 4 | SM00194 | |
| Domain | EF-hand_1 | 2.11e-03 | 152 | 280 | 8 | PF00036 | |
| Domain | - | 2.17e-03 | 5 | 280 | 2 | 3.90.1140.10 | |
| Domain | FYRC | 2.17e-03 | 5 | 280 | 2 | SM00542 | |
| Domain | FYRN | 2.17e-03 | 5 | 280 | 2 | SM00541 | |
| Domain | EHD_N | 2.17e-03 | 5 | 280 | 2 | IPR031692 | |
| Domain | Myosin_S1_N | 2.17e-03 | 5 | 280 | 2 | IPR008989 | |
| Domain | FYRN | 2.17e-03 | 5 | 280 | 2 | PF05964 | |
| Domain | FYRC | 2.17e-03 | 5 | 280 | 2 | PF05965 | |
| Domain | FYrich_C | 2.17e-03 | 5 | 280 | 2 | IPR003889 | |
| Domain | FYrich_N | 2.17e-03 | 5 | 280 | 2 | IPR003888 | |
| Domain | YD | 2.17e-03 | 5 | 280 | 2 | IPR006530 | |
| Domain | EHD_N | 2.17e-03 | 5 | 280 | 2 | PF16880 | |
| Domain | FYRC | 2.17e-03 | 5 | 280 | 2 | PS51543 | |
| Domain | FYRN | 2.17e-03 | 5 | 280 | 2 | PS51542 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.69e-03 | 39 | 280 | 4 | PS50055 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.66e-05 | 11 | 217 | 4 | M47958 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3I TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3L TBC1D3D TBC1D3C | 2.81e-15 | 11 | 283 | 8 | 16863688 |
| Pubmed | MYH10 MYO1D MYO5B RPS4X RPS4Y1 RPS15 UPF3B EHD3 NEFM NEFH LONP1 NWD2 NDUFA12 CAMKV SACS EHD1 EIF3L CLTC KMT2A PYGB DCLK2 KIF2A ALDH1B1 TARS1 RPS4Y2 CUL3 CACNA1A SRSF5 LARP1 SRGAP2 GRIN2A GRIN2B SIPA1 GRM1 PPP1CB TENM4 P2RX3 G3BP1 KNDC1 OTUD4 DNAH11 | 2.72e-12 | 1431 | 283 | 41 | 37142655 | |
| Pubmed | RGPD4 CEP104 MYH10 TCERG1L MYO1D MYO5B RPS4X RPS4Y1 GARS1 NOL6 ASH1L DGKA CLPX RYR2 NEFM NDUFA12 GAR1 NRXN1 SACS CLTC KMT2A CDNF ATP11A ALDH1B1 DMWD RPS4Y2 CACNA1E RGPD2 ADAP1 PCDHGA11 DDX52 LARP1 TWNK C2orf78 PPP1CB CTR9 GNA13 MYOM2 STAG2 SPATA13 | 1.39e-11 | 1442 | 283 | 40 | 35575683 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 GBF1 MYO1D RPS4X MRPL44 GARS1 GART NOL6 SMARCAD1 UPF3B CLPX PLA2G15 PTPN1 LONP1 NOP9 GAR1 VPS33B EIF3L CLTC KIF2A GNAS ALDH1B1 TARS1 SRSF5 SRSF6 DNAH10 DHX37 DDX52 POLR2B OTUB1 LARP1 FASTKD2 GRM1 G3BP1 MTOR CTR9 CTPS1 SNRPB2 STAG2 | 3.83e-11 | 1425 | 283 | 39 | 30948266 |
| Pubmed | MYH10 MYO1D RPS4X GART NOL6 RPS15 NEFM LONP1 EIF3L CLTC KMT2A PYGB PYGL HERC2 SRSF5 DHX37 DDX52 LARP1 ZCCHC3 PPP1CB G3BP1 MTOR SMARCA2 STAG2 XPO7 | 2.03e-10 | 653 | 283 | 25 | 22586326 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH10 MYO5B RPS4X RPS4Y1 DGKA PICALM EHD3 NEFM NEFH EHD1 ADAMTS20 PYGB PYGL PYGM KIF2A GNAS RPS4Y2 SRSF5 OTUB1 GRIN2A GRIN2B MTOR GNA13 | 2.08e-09 | 621 | 283 | 23 | 22794259 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HEXA GBF1 RPS4X GARS1 GART PBDC1 RPS15 NAP1L4 SMARCAD1 DDB2 UFD1 EHD1 EIF3L PYGB PYGL ALDH1B1 TARS1 CUL3 AMPD2 SRSF5 SRSF6 ATG7 POLR2B LARP1 PTPN23 ARMC9 NUDCD3 PPP1CB G3BP1 MTOR CTR9 PANK4 CTPS1 SNRPB2 SNX1 XPO7 | 3.41e-09 | 1455 | 283 | 36 | 22863883 |
| Pubmed | 4.29e-09 | 4 | 283 | 4 | 8406013 | ||
| Pubmed | RGPD4 MYH10 VWA8 RPS4X RPS4Y1 NAP1L4 RYR2 PTPN1 LONP1 NDUFA12 NRXN1 CAMKV CLTC PYGB TACC1 DCLK2 KIF2A ALDH1B1 AKAP7 RPS4Y2 CACNA1A RGPD2 AMPD2 GRIN2A GRIN2B PPP1CB TENM4 PPP3R1 G3BP1 KNDC1 SNX1 | 5.22e-09 | 1139 | 283 | 31 | 36417873 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 RPS4X GARS1 GART NOL6 RPS15 SMARCAD1 CLPX LONP1 VPS33B PIK3C2A UFD1 EHD1 EIF3L CLTC PYGB PYGL KIF2A ALDH1B1 HERC2 TARS1 TTF2 SRSF6 DHX37 DDX52 POLR2B WDR70 PTPN23 FASTKD2 PPP1CB G3BP1 CTR9 SMARCA2 CTPS1 | 6.61e-09 | 1353 | 283 | 34 | 29467282 |
| Pubmed | RPS4X RPS4Y1 MRPL44 GARS1 RPS15 NAP1L4 NDUFA12 GAR1 FDFT1 EIF3L CLTC FGFR3 ALDH1B1 AKAP7 HSP90AB3P RPS4Y2 SRSF5 SRSF6 LARP1 BUD13 TWNK CEP192 LARP1B ZCCHC3 PPP1CB P2RX3 G3BP1 CTR9 SNRPB2 SPATA13 TGS1 | 6.93e-09 | 1153 | 283 | 31 | 29845934 | |
| Pubmed | RGPD4 MYH10 PLA2G15 PICALM EHD3 NEFM NEFH PTPRD NRXN1 CAMKV CLTC KIF2A HERC2 CUL3 CACNA1A CACNA1E RGPD2 AMPD2 SRGAP2 GRIN2A GRIN2B SIPA1 GRM1 PPP1CB G3BP1 MTOR OTUD4 SPATA13 | 7.45e-09 | 963 | 283 | 28 | 28671696 | |
| Pubmed | MYH10 MYO1D MYO5B RPS4X GARS1 GART RPS15 UPF3B AHDC1 NFU1 AXIN2 LONP1 PIK3C2A CLTC MLLT3 KIF2A GNAS ALDH1B1 TARS1 SRSF5 SRSF6 DDX52 POLR2B ASCC1 LARP1 BUD13 PPP1CB G3BP1 EPHA2 SMARCA2 OTUD4 SNRPB2 | 1.17e-08 | 1247 | 283 | 32 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 GBF1 RPS4X GARS1 GART PBDC1 RPS15 NAP1L4 CLPX PTPN1 FDFT1 UFD1 CLTC PYGB PYGL GNAS ALDH1B1 TARS1 CUL3 TTF2 RGPD2 SRSF6 DHX37 POLR2B LARP1 PPP1CB G3BP1 CTR9 PANK4 CTPS1 SNRPB2 PRAME | 1.41e-08 | 1257 | 283 | 32 | 37317656 |
| Pubmed | 2.13e-08 | 5 | 283 | 4 | 12604796 | ||
| Pubmed | 2.13e-08 | 5 | 283 | 4 | 8471161 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH10 VWA8 NOL6 PBDC1 UPF3B CLPX DDB2 LONP1 GAR1 PIK3C2A UFD1 EIF3L PYGL HERC2 DMWD AKAP7 CUL3 OTUB1 WDR70 ZYG11B CEP192 NUDCD3 USP6 G3BP1 GNA13 SMARCA2 OTUD4 | 7.02e-08 | 1005 | 283 | 27 | 19615732 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | NEFM SACS CLTC GNAS CUL3 CACNA1E SRGAP2 GRIN2A GRIN2B GRM1 PPP1CB CAMKK2 MTOR GNA13 | 9.22e-08 | 281 | 283 | 14 | 28706196 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH10 VWA8 RPS4X GARS1 GART RPS15 NAP1L4 SMARCAD1 UPF3B CLPX LONP1 GAR1 UFD1 EIF3L CLTC KIF2A TARS1 AMPD2 SRSF5 SRSF6 POLR2B LARP1 PTPN23 SRGAP2 PPP1CB G3BP1 CTR9 DECR2 CTPS1 SNRPB2 STAG2 SNX1 | 2.09e-07 | 1415 | 283 | 32 | 28515276 |
| Pubmed | MYH10 SMARCAD1 FHIP1B NEFH CLTC ARAP2 ZYG11B CEP192 LRIG3 CAMKK2 TENM4 TENM3 OTUD4 ULK2 SPATA13 XPO7 | 2.84e-07 | 407 | 283 | 16 | 12693553 | |
| Pubmed | MYH10 GBF1 MYO5B VWA8 GARS1 SMARCAD1 CLPX PICALM LONP1 FDFT1 EHD1 CLTC SRSF5 SRSF6 FASTKD2 SIPA1 PPP1CB FRMD6 SMARCA2 XPO7 | 3.19e-07 | 634 | 283 | 20 | 34591612 | |
| Pubmed | HEXA GBF1 RPS4X RPS4Y1 RPS15 DGKA NCAPH2 PICALM LCLAT1 LONP1 PIK3C2A EHD1 EIF3L CLTC PYGB ATP11A KIF2A GNAS HERC2 CUL3 DDX52 HTATIP2 LARP1 PARP14 MTOR GNA13 CTPS1 STAG2 | 4.03e-07 | 1168 | 283 | 28 | 19946888 | |
| Pubmed | A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships. | 5.24e-07 | 9 | 283 | 4 | 30377379 | |
| Pubmed | 5.33e-07 | 3 | 283 | 3 | 8808278 | ||
| Pubmed | 5.33e-07 | 3 | 283 | 3 | 1783379 | ||
| Pubmed | 5.33e-07 | 3 | 283 | 3 | 2124517 | ||
| Pubmed | 5.33e-07 | 3 | 283 | 3 | 8187552 | ||
| Pubmed | MYH10 MYO1D MYO5B RPS15 CLPX PTPN1 LONP1 PTPRD PTPRF VPS33B FDFT1 CLTC HERC2 DMWD POLR2B PTPN23 ZYG11B CEP192 NUDCD3 RCAN3 PPP1CB PPP3R1 CTR9 OTUD4 PLEKHA1 SIX2 | 5.75e-07 | 1049 | 283 | 26 | 27880917 | |
| Pubmed | MYO1D RPS4X MRPL44 GARS1 GART PBDC1 RPS15 NAP1L4 KIAA1143 LONP1 GAR1 UFD1 EIF3L CLTC KIF2A GNAS ALDH1B1 TARS1 HSP90AB3P CUL3 SRSF6 ATG7 DDX52 POLR2B ASCC1 LARP1 FASTKD2 G3BP1 CTPS1 SNRPB2 | 5.87e-07 | 1335 | 283 | 30 | 29229926 | |
| Pubmed | MYH10 VWA8 NOL6 RPS15 NAP1L4 CLPX PICALM LCLAT1 PTPN1 LONP1 NOP9 PIK3C2A FDFT1 UFD1 EHD1 EIF3L CLTC KMT2A GNAS ALDH1B1 SRSF5 SRSF6 POLR2B OTUB1 ASCC1 LARP1 G3BP1 MTOR PANK4 CTPS1 STAG2 | 9.32e-07 | 1440 | 283 | 31 | 30833792 | |
| Pubmed | ASH1L DGKA PLA2G15 LCLAT1 EHD3 VPS33B CLTC ATP11A KIF2A DMWD PCDH18 AMPD2 DDX52 POLR2B PTPN23 SRGAP2 CEP192 CPT2 TGM4 AOPEP CTR9 OTUD4 ESPL1 ULK2 STAG2 TGS1 | 1.06e-06 | 1084 | 283 | 26 | 11544199 | |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 1.35e-06 | 11 | 283 | 4 | 15944372 | |
| Pubmed | MYH10 GBF1 RPS4X GART NAP1L4 PICALM LONP1 EIF3L CLTC KIF2A TARS1 DDX52 POLR2B PTPN23 G3BP1 MTOR CTR9 CTPS1 STAG2 | 1.48e-06 | 638 | 283 | 19 | 33239621 | |
| Pubmed | HEXA MYH10 RPS4X GART NOL6 RPS15 CLPX PTPN1 GAR1 FDFT1 KIF2A TARS1 G3BP1 CTR9 CTPS1 STAG2 | 1.54e-06 | 463 | 283 | 16 | 34901782 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH10 MYO1D MYO5B RPS4X GARS1 GART NOL6 RPS15 PTPN1 GAR1 SRGAP1 EIF3L CLTC KIF2A GNAS TARS1 CUL3 SRSF6 DHX37 DDX52 POLR2B ASCC1 LARP1 BUD13 ZCCHC3 PPP1CB G3BP1 CTPS1 | 1.69e-06 | 1257 | 283 | 28 | 36526897 |
| Pubmed | VWA8 MRPL44 PBDC1 NAP1L4 SMARCAD1 CLPX PTPN1 NDUFA12 PIK3C2A SACS FDFT1 CLTC TACC1 GNAS HERC2 TARS1 SRSF6 POLR2B OTUB1 ASCC1 TWNK FASTKD2 CEP192 NUDCD3 CAMKK2 CTR9 EPHA2 PANK4 PLEKHA1 ESPL1 SNX1 | 1.81e-06 | 1487 | 283 | 31 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYH10 INPP5A ASH1L ATP8B1 AHDC1 CASZ1 EHD3 RAB28 PVR ATP11A DCLK2 GNAS GULP1 ENOSF1 ATG7 MAN1C1 WDR70 LARP1 SLITRK3 SRGAP2 CEP192 NUDCD3 PPP1CB AOPEP PANK4 SMARCA2 KNDC1 PLEKHA2 KAT6B STAG2 XPO7 | 1.86e-06 | 1489 | 283 | 31 | 28611215 |
| Pubmed | 2.02e-06 | 12 | 283 | 4 | 12460940 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYH10 MYO1D VWA8 MRPL44 GARS1 UPF3B CLPX NFU1 PTPN1 LONP1 NDUFA12 VPS33B PIK3C2A CLTC TACC1 KIF2A GNAS ALDH1B1 HERC2 TTF2 POLR2B TWNK FASTKD2 NUDCD3 LARP1B CPT2 ZCCHC3 SNIP1 PANK4 ESPL1 PRAME | 2.05e-06 | 1496 | 283 | 31 | 32877691 |
| Pubmed | MYH10 KMT2B ASH1L RYR2 PTPRF EIF3L HERC2 TTF2 NPR1 ZNF484 MAN1C1 OTUB1 TWNK RGS3 PPP1CB SNIP1 TENM3 CTR9 | 2.06e-06 | 591 | 283 | 18 | 15231748 | |
| Pubmed | Structure and function of ribosomal protein S4 genes on the human and mouse sex chromosomes. | 2.12e-06 | 4 | 283 | 3 | 8139551 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 2.12e-06 | 4 | 283 | 3 | 12359748 | |
| Pubmed | 2.12e-06 | 4 | 283 | 3 | 28600513 | ||
| Pubmed | 2.12e-06 | 4 | 283 | 3 | 27346147 | ||
| Pubmed | Bioengineering murine mastocytoma cells to produce anticoagulant heparin. | 2.12e-06 | 4 | 283 | 3 | 24326668 | |
| Pubmed | Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia. | 2.12e-06 | 4 | 283 | 3 | 27071307 | |
| Pubmed | MYH10 RPS4X GART RPS15 LONP1 GAR1 SRGAP1 CLTC KMT2A PYGL SRSF5 POLR2B OTUB1 ASCC1 LARP1 PPP1CB G3BP1 OTUD4 | 2.60e-06 | 601 | 283 | 18 | 33658012 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 GARS1 NAP1L4 CLPX DDB2 GAR1 EIF3L CLTC PYGM GNAS HERC2 CUL3 RGPD2 NPR1 SRSF5 SRSF6 LARP1 BUD13 CEP192 MAU2 PPP1CB SMARCA2 ESPL1 SNRPB2 STAG2 TGS1 | 3.35e-06 | 1155 | 283 | 26 | 20360068 |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 3.56e-06 | 147 | 283 | 9 | 28977470 | |
| Pubmed | GBF1 DDB2 NEFM LONP1 PIK3C2A CLTC TARS1 CUL3 ATG7 TWNK NUDCD3 CAMKK2 G3BP1 MTOR ULK2 | 3.56e-06 | 437 | 283 | 15 | 20562859 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | RGPD4 NRXN1 HS6ST1 ELOVL6 ARAP2 CMKLR2 RGPD2 HTR2B ARMC9 FASTKD2 APLF PPP1CB PPP3R1 TENM3 TRMT44 | 4.09e-06 | 442 | 283 | 15 | 15815621 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CYP2B6 CHIA CATSPERE GBF1 MAB21L4 PBDC1 NCAPH2 KIAA1143 PTPRD VPS33B FDFT1 EHD1 ATP11A PXYLP1 ALDH1B1 ARAP2 ADAP1 MAU2 GRIN2A CPT2 DENND4C ARSG SNIP1 RPIA RDH16 MTOR CTR9 | 4.10e-06 | 1242 | 283 | 27 | 30973865 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH10 RPS4X RPS4Y1 GARS1 GART NOL6 RPS15 CLPX LONP1 GAR1 FDFT1 EIF3L CLTC KMT2A PYGL KIF2A SRSF6 DHX37 DDX52 POLR2B LARP1 FASTKD2 ZCCHC3 SNIP1 CTR9 SMARCA2 CTPS1 SNRPB2 | 4.16e-06 | 1318 | 283 | 28 | 30463901 |
| Pubmed | GBF1 RUNDC3B LONP1 VPS33B PIK3C2A KIF2A TTF2 AMPD2 LARP1 TBC1D22B SRGAP2 CEP192 TEAD1 DENND4C PLEKHA1 | 4.55e-06 | 446 | 283 | 15 | 24255178 | |
| Pubmed | MYH10 GART NAP1L4 CLPX EIF3L PYGB PYGL KIF2A TARS1 KLB CUL3 POLR2B WDR70 G3BP1 PANK4 | 5.21e-06 | 451 | 283 | 15 | 36168627 | |
| Pubmed | 5.27e-06 | 5 | 283 | 3 | 18082335 | ||
| Pubmed | Maintenance of X inactivation of the Rps4, Zfx, and Ube1 genes in a mouse in vitro system. | 5.27e-06 | 5 | 283 | 3 | 7681608 | |
| Pubmed | 5.27e-06 | 5 | 283 | 3 | 9562962 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GBF1 RPS15 NAP1L4 NCAPH2 PICALM PTPN1 PTPRD PTPRF UFD1 PYGL GNAS HSP90AB3P SRSF5 OTUB1 WDR70 PTPN23 FUOM SIX1 MTOR CTR9 EPHA2 ESPL1 GPSM1 | 5.85e-06 | 974 | 283 | 23 | 28675297 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 KMT2B SMARCAD1 CLTC KMT2A DMWD CUL3 SRSF5 SRSF6 LARP1 BUD13 PPP1CB G3BP1 CTR9 SMARCA2 OTUD4 CTPS1 KAT6B ESPL1 STAG2 | 6.60e-06 | 774 | 283 | 20 | 15302935 |
| Pubmed | GBF1 KMT2B RPS4X GARS1 DDB2 PTPN1 LONP1 FDFT1 EHD1 EIF3L CLTC KMT2A ALDH1B1 LARP1 FASTKD2 PARP14 ZCCHC3 PPP1CB G3BP1 | 7.04e-06 | 711 | 283 | 19 | 33022573 | |
| Pubmed | 7.23e-06 | 16 | 283 | 4 | 30466882 | ||
| Pubmed | 7.90e-06 | 34 | 283 | 5 | 28069946 | ||
| Pubmed | HEXA MYH10 GARS1 GART SMARCAD1 UPF3B CLPX FAT1 PVR EIF3L CLTC ATP11A GNAS COL12A1 DHX37 POLR2B OTUB1 LARP1 PTPN23 FASTKD2 PPP1CB G3BP1 GNA13 PLEKHA2 NAA30 CTPS1 SNX1 | 8.96e-06 | 1297 | 283 | 27 | 33545068 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH10 GBF1 RPS4X GARS1 GART RPS15 NAP1L4 NEFM EIF3L CLTC PYGL GNAS TARS1 CUL3 SRSF5 POLR2B OTUB1 LARP1 SRGAP2 CPT2 PPP1CB G3BP1 PANK4 OTUD4 CTPS1 | 9.32e-06 | 1149 | 283 | 25 | 35446349 |
| Pubmed | A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales. | 9.40e-06 | 17 | 283 | 4 | 22832960 | |
| Pubmed | 9.40e-06 | 17 | 283 | 4 | 29771971 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GBF1 RPS4Y1 UPF3B FAT1 FGFR3 CUL3 SRSF5 SRSF6 WDR70 BUD13 ARSG PPP1CB SNIP1 | 9.61e-06 | 361 | 283 | 13 | 26167880 |
| Pubmed | SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. | 1.05e-05 | 6 | 283 | 3 | 33514561 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.05e-05 | 6 | 283 | 3 | 12827191 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | MYH10 MYO1D MYO5B RPS4X RPS4Y1 CLTC GNAS LARP1 PPP1CB G3BP1 PRAME | 1.22e-05 | 264 | 283 | 11 | 32814769 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MYO5B GARS1 NCAPH2 EHD3 NEFM LONP1 RAB28 NRXN1 EIF3L PYGL CCDC40 HSP90AB3P CUL3 AMPD2 SRSF5 SRSF6 OTUB1 WDR70 LARP1 ZYG11B SRGAP2 DENND4C PPP1CB MTOR CTR9 SNRPB2 PRAME | 1.24e-05 | 1321 | 283 | 27 | 27173435 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D MYO5B RPS4X GART NOL6 LONP1 NOP9 PTPRF GAR1 SACS CLTC KIF2A GNAS HERC2 TARS1 SRSF6 DDX52 POLR2B G3BP1 GNA13 SNRPB2 STAG2 XPO7 | 1.30e-05 | 1024 | 283 | 23 | 24711643 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.39e-05 | 38 | 283 | 5 | 30786075 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RPS4X NAP1L4 UPF3B PICALM EIF3L MLLT3 GNAS DMWD TTF2 SRSF5 SRSF6 POLR2B WDR70 ASCC1 DENND4C MTOR CTR9 KNDC1 OTUD4 ESPL1 SNRPB2 GPSM1 TGS1 | 1.61e-05 | 1038 | 283 | 23 | 26673895 |
| Pubmed | VWA8 MRPL44 GARS1 CLPX NFU1 LONP1 NDUFA12 GNAS ALDH1B1 HERC2 DHX37 TWNK FASTKD2 CPT2 | 1.67e-05 | 438 | 283 | 14 | 32628020 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 MYH10 MYO1D RPS4X RPS15 NAP1L4 CASZ1 GAR1 CLTC KIF2A HERC2 SRSF5 SRSF6 LARP1 TWNK PPP1CB G3BP1 | 1.75e-05 | 626 | 283 | 17 | 33644029 |
| Pubmed | RPS4X RPS15 UPF3B CLPX CMC2 GAR1 EIF3L GNAS TTF2 SRSF5 SRSF6 DHX37 POLR2B ASCC1 LARP1 LARP1B APLF ZCCHC3 PPP1CB SNIP1 G3BP1 CTR9 | 1.77e-05 | 971 | 283 | 22 | 33306668 | |
| Pubmed | MYH10 MYO1D RPS4X GARS1 GART GAR1 EIF3L HERC2 POLR2B LARP1 TWNK CTPS1 SNRPB2 | 1.79e-05 | 383 | 283 | 13 | 29331416 | |
| Pubmed | 1.82e-05 | 7 | 283 | 3 | 7928394 | ||
| Pubmed | An evaluation of the inactive mouse X chromosome in somatic cell hybrids. | 1.82e-05 | 7 | 283 | 3 | 8460399 | |
| Pubmed | Chondroitin sulfate enhances the barrier function of basement membrane assembled by heparan sulfate. | 1.82e-05 | 7 | 283 | 3 | 35608020 | |
| Pubmed | Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M. | 1.82e-05 | 7 | 283 | 3 | 28389568 | |
| Pubmed | 1.82e-05 | 7 | 283 | 3 | 32848623 | ||
| Pubmed | 1.82e-05 | 7 | 283 | 3 | 29107521 | ||
| Pubmed | 1.88e-05 | 20 | 283 | 4 | 16635246 | ||
| Pubmed | Role of heparan sulfate proteoglycans in optic disc and stalk morphogenesis. | 1.88e-05 | 20 | 283 | 4 | 24753163 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH10 GBF1 MYO1D MRPL44 GART CLPX FDFT1 EIF3L CLTC PYGM GNAS HERC2 TARS1 SRSF6 DHX37 POLR2B LARP1 SRGAP2 PPP1CB LOXHD1 G3BP1 FRMD6 OTUD4 CTPS1 SNRPB2 XPO7 | 2.12e-05 | 1284 | 283 | 26 | 17353931 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RPS4X NOL6 SMARCAD1 CLPX PTPN1 NOP9 VPS33B EIF3L CLTC TTF2 DHX37 DDX52 POLR2B PTPN23 PPP1CB MTOR SMARCA2 CTPS1 | 2.21e-05 | 704 | 283 | 18 | 29955894 |
| Pubmed | A Cxcl12-CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons. | 2.30e-05 | 21 | 283 | 4 | 16129397 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 2.37e-05 | 186 | 283 | 9 | 33637726 | |
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 2.38e-05 | 104 | 283 | 7 | 26167872 | |
| Pubmed | MYH10 GBF1 VWA8 GARS1 NOL6 UPF3B CLPX GAR1 PIK3C2A EHD1 CLTC KMT2A FLRT3 GNAS HERC2 SRSF5 DHX37 DDX52 LARP1 LARP1B PPP1CB SNIP1 G3BP1 EPHA2 OTUD4 DECR2 SNRPB2 | 2.38e-05 | 1371 | 283 | 27 | 36244648 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HEXA VWA8 RPS4X RPS4Y1 MRPL44 GARS1 GART CLPX CMC2 NFU1 LCLAT1 LONP1 FAT1 NDUFA12 PVR CLTC GNAS RPS4Y2 AMPD2 PTPN23 FASTKD2 CPT2 SNIP1 RPIA NEIL3 CTPS1 SNRPB2 XPO7 | 2.40e-05 | 1451 | 283 | 28 | 30550785 |
| Pubmed | NBEAL1 FHIP1B PICALM PTPN1 VPS33B PIK3C2A EHD1 GULP1 DHX37 PLEKHA1 SNX1 | 2.48e-05 | 285 | 283 | 11 | 34369648 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | MYO5B RPS4X GART NOL6 RPS15 GAR1 CLTC TTF2 SRSF6 DHX37 POLR2B LARP1 TEAD1 SIX1 OTUD4 CTPS1 | 2.73e-05 | 583 | 283 | 16 | 29844126 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | MYO5B MRPL44 NOL6 SACS KIF2A TARS1 CUL3 DHX37 WDR70 CPT2 MTOR CTR9 OTUD4 | 2.82e-05 | 400 | 283 | 13 | 35013556 |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 2.90e-05 | 8 | 283 | 3 | 23130995 | |
| Pubmed | 2.90e-05 | 8 | 283 | 3 | 37591863 | ||
| Pubmed | 2.90e-05 | 8 | 283 | 3 | 16489129 | ||
| Interaction | PDGFRA interactions | MYO1D CHST14 HS6ST2 HS6ST1 EHD1 PXYLP1 FGFR3 GNAS PDGFC HS3ST1 TPST1 CHST10 NDST2 TTYH2 GRM1 ARSG MTOR EPHA2 DECR2 | 1.76e-06 | 385 | 277 | 19 | int:PDGFRA |
| Interaction | KCTD13 interactions | MYH10 MYO1D MYO5B RPS4X RPS15 UPF3B EHD3 NEFM NEFH LONP1 NWD2 NDUFA12 CAMKV SACS EHD1 EIF3L CLTC KMT2A PYGB DCLK2 KIF2A ALDH1B1 TARS1 CUL3 CACNA1A SRSF5 LARP1 TWNK SRGAP2 GRIN2A GRIN2B SIPA1 GRM1 PPP1CB TENM4 P2RX3 G3BP1 KNDC1 OTUD4 DNAH11 | 7.68e-06 | 1394 | 277 | 40 | int:KCTD13 |
| Interaction | CTPS2 interactions | 1.37e-05 | 131 | 277 | 10 | int:CTPS2 | |
| Interaction | FKBP5 interactions | GART CAMKV PIK3C2A SACS PYGB PYGL DCLK2 ALDH1B1 TTF2 ATG7 DDX52 POLR2B NUDCD3 CAMKK2 PRKACG NEIL3 ESPL1 PSKH2 | 1.86e-05 | 414 | 277 | 18 | int:FKBP5 |
| Interaction | CIT interactions | MYH10 VWA8 RPS4X RPS4Y1 GART NOL6 ASH1L RPS15 UPF3B CLPX PICALM NEFM LONP1 NOP9 GAR1 EIF3L CLTC KMT2A KIF2A GNAS CCDC40 HSP90AB3P RPS4Y2 CUL3 SRSF5 SRSF6 POLR2B LARP1 MAU2 GRIN2B TEAD1 PPP1CB ESYT3 G3BP1 CTR9 PANK4 SMARCA2 MYOM2 SNRPB2 STAG2 | 1.92e-05 | 1450 | 277 | 40 | int:CIT |
| Interaction | KIF20A interactions | RGPD4 MYH10 MYO1D VWA8 RPS4X HS6ST2 RPS4Y1 NOL6 RPS15 NAP1L4 PICALM NEFM LONP1 GAR1 PIK3C2A ASB7 CLTC GNAS ALDH1B1 HERC2 KLB RPS4Y2 CUL3 SRSF5 SRSF6 LARP1 PTPN23 SIPA1 PPP1CB G3BP1 SMARCA2 SNRPB2 | 2.22e-05 | 1052 | 277 | 32 | int:KIF20A |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3I TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3L TBC1D3D DDX52 TBC1D3C | 4.16e-07 | 149 | 283 | 9 | chr17q12 |
| GeneFamily | Sulfotransferases, membrane bound | 1.04e-07 | 37 | 191 | 7 | 763 | |
| GeneFamily | Glycogen phosphorylases | 1.16e-06 | 3 | 191 | 3 | 437 | |
| GeneFamily | Chitinases | 3.94e-05 | 7 | 191 | 3 | 816 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.31e-04 | 3 | 191 | 2 | 287 | |
| GeneFamily | S ribosomal proteins | 4.37e-04 | 34 | 191 | 4 | 728 | |
| GeneFamily | EF-hand domain containing | 5.47e-04 | 219 | 191 | 9 | 863 | |
| GeneFamily | Fibronectin type III domain containing | 1.58e-03 | 160 | 191 | 7 | 555 | |
| GeneFamily | SINE class homeoboxes | 1.62e-03 | 6 | 191 | 2 | 525 | |
| GeneFamily | Intermediate filaments Type IV | 1.62e-03 | 6 | 191 | 2 | 611 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 2.25e-03 | 7 | 191 | 2 | 135 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 2.25e-03 | 7 | 191 | 2 | 625 | |
| GeneFamily | Guanylate cyclase receptors | 2.25e-03 | 7 | 191 | 2 | 343 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 2.25e-03 | 7 | 191 | 2 | 1201 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | RGPD4 GBF1 COX16 INPP5A HS6ST2 GART FHIP1B FAT1 PTPRD NDUFA12 SACS ASB7 GNAS HERC2 PDGFC CUL3 TPST1 SRSF5 SRSF6 MAN1C1 CASQ2 FASTKD2 FCRLA LARP1B APLF RGS3 LRIG3 TENM3 AOPEP CTR9 GNA13 SMARCA2 SPATA13 XPO7 | 3.61e-09 | 1009 | 280 | 34 | M157 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | MYO1D NPAS3 PICALM RYR3 FAT1 PTPRD SRGAP1 GULP1 SRGAP2 TEAD1 TENM3 | 1.91e-05 | 212 | 280 | 11 | M39221 |
| Coexpression | GAUTAM_EYE_CHOROID_SCLERA_MONOCYTES | 1.95e-05 | 139 | 280 | 9 | M43604 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | CEP104 GBF1 INPP5A PICALM AHDC1 KIAA1143 PRDM10 PTPRF KMT2A ATG7 MAN1C1 NDST2 ASCC1 BUD13 ZYG11B RCAN3 SNIP1 TENM4 MTOR PANK4 PLEKHA1 HYI KAT6B | 2.14e-05 | 807 | 280 | 23 | M14594 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.20e-05 | 94 | 277 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | PLCXD2 NPAS3 BRINP1 AXIN2 ADAMTS20 MLLT3 PXYLP1 FLRT3 PCDH18 WNT7A PCDHB13 PCDHB12 SIX1 FRMD6 AOPEP KAT6B | 3.93e-05 | 377 | 277 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 5.55e-05 | 75 | 277 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | VWA8 NPAS3 DGKA BRINP1 RYR3 NEFM PIK3C2A SRGAP1 ADAMTS20 MLLT3 PCDH18 GULP1 DHX37 PCDHB12 ZYG11B SRGAP2 TEAD1 SIX1 LRIG3 TENM4 PPP3R1 GNA13 OTUD4 MYOM2 SIX2 | 6.01e-05 | 806 | 277 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | HS6ST2 NPAS3 RYR2 PYGB ALDH1B1 BACE2 AKAP7 COL12A1 DENND4C FRMD6 | 6.76e-05 | 166 | 277 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_1000 |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | RUNDC3B PLCXD2 CCR9 DGKA EHD3 PTPRF PVR MLLT3 CCR7 ARAP2 CHST10 TBC1D22B RGS3 RCAN3 SPATA13 | 9.79e-05 | 365 | 277 | 15 | GSM399376_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | RUNDC3B PLCXD2 DGKA FHIP1B JAML AXIN2 EHD3 NEFH MLLT3 PXYLP1 ARAP2 CHST10 TBC1D22B DENND4C SPATA13 | 1.04e-04 | 367 | 277 | 15 | GSM538401_500 |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | RUNDC3B PLCXD2 CCR9 DGKA EHD3 CXCR5 NEFH PVR KMT2A MLLT3 CCR7 ARAP2 SEC14L1 SPATA13 | 1.12e-04 | 328 | 277 | 14 | GSM605756_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3 | RUNDC3B PLCXD2 GART DGKA JAML AXIN2 EHD3 CXCR5 NEFH PXYLP1 CCR7 CHST10 TBC1D22B SPATA13 | 1.16e-04 | 329 | 277 | 14 | GSM538395_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | MYO5B VWA8 HS6ST2 RYR2 AXIN2 PTPRF PIK3C2A HS6ST1 PYGB PYGL MLLT3 ALDH1B1 BACE2 PCDH18 COL12A1 CPT2 DENND4C CAMKK2 TENM3 FRMD6 PLEKHA2 DECR2 HYI KAT6B | 1.49e-04 | 803 | 277 | 24 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | NPAS3 ATP8B1 RYR3 NEFM PTPRD TC2N PIK3C2A SRGAP1 MLLT3 HERC2 PDGFC PCDH18 ARAP2 GULP1 PCDHB13 PCDHB12 TEAD1 SIX1 TENM4 CTR9 GNA13 OTUD4 NAA30 SIX2 | 1.57e-04 | 806 | 277 | 24 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | 1.77e-04 | 90 | 277 | 7 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.81e-04 | 120 | 277 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 1.86e-04 | 64 | 277 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | RUNDC3B PLCXD2 DGKA JAML AXIN2 EHD3 CXCR5 MLLT3 PXYLP1 CCR7 TBC1D22B DENND4C SPATA13 | 1.87e-04 | 303 | 277 | 13 | GSM538398_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | NPAS3 BACE1 BRINP1 RYR2 RYR3 NEFM PTPRF PIK3C2A ADAMTS20 KIF2A FLRT3 HERC2 GULP1 PCDHB13 PCDHB12 TEAD1 SIX1 CAMKK2 CASD1 TENM4 GNA13 OTUD4 KAT6B GPSM1 | 1.96e-04 | 818 | 277 | 24 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | MYO5B HS6ST2 NPAS3 RYR2 AXIN2 NEFM PTPRD PTPRF HS6ST1 PYGB ALDH1B1 BACE2 PDGFC PCDH18 AKAP7 COL12A1 DENND4C TENM4 TENM3 FRMD6 PLEKHA2 KAT6B TGS1 | 2.62e-04 | 783 | 277 | 23 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 2.73e-04 | 161 | 277 | 9 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_500 | |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | RUNDC3B PLCXD2 DGKA AXIN2 EHD3 CXCR5 PVR MLLT3 PXYLP1 CCR7 CHST10 TBC1D22B RCAN3 SPATA13 | 2.85e-04 | 359 | 277 | 14 | GSM404000_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR2 RYR3 FAT1 PTPRD NRXN1 ADAMTS20 COL12A1 DNAH10 GRIN2B GRM1 LOXHD1 TENM4 GUCY2F MYOM2 DNAH11 | 1.02e-12 | 184 | 283 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR2 RYR3 FAT1 PTPRD NRXN1 ADAMTS20 COL12A1 DNAH10 GRIN2B GRM1 LOXHD1 TENM4 GUCY2F MYOM2 DNAH11 | 1.02e-12 | 184 | 283 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR2 RYR3 FAT1 PTPRD NRXN1 ADAMTS20 COL12A1 DNAH10 GRIN2B GRM1 LOXHD1 TENM4 GUCY2F MYOM2 DNAH11 | 1.02e-12 | 184 | 283 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR2 NEFM NEFH CAMKV CACNA1A CACNA1E SLITRK3 GRIN2B GRM1 TENM4 NECAB3 | 4.74e-08 | 193 | 283 | 11 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR2 NEFM NEFH CAMKV CACNA1A CACNA1E SLITRK3 GRIN2B GRM1 TENM4 NECAB3 | 4.74e-08 | 193 | 283 | 11 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR2 NEFM NEFH CAMKV CACNA1A CACNA1E SLITRK3 GRIN2B GRM1 TENM4 NECAB3 | 4.74e-08 | 193 | 283 | 11 | 0c652ebe22ce5d2927599dd97ef1920547858395 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | RUNDC3B RYR2 NEFM PTPRD NRXN1 CAMKV SRGAP1 AKAP7 CACNA1E GRIN2B RASL11B | 6.82e-08 | 200 | 283 | 11 | db10f76938af553d1a2275bb02ef75dff3c3135b |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | RUNDC3B RYR2 NEFM PTPRD NRXN1 CAMKV SRGAP1 AKAP7 CACNA1E GRIN2B RASL11B | 6.82e-08 | 200 | 283 | 11 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO5B RYR3 PRDM10 TC2N CCR7 CACNA1A HTR2B DNAH10 ARMC9 EPHA2 | 3.18e-07 | 185 | 283 | 10 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GBF1 PLCXD2 ATP8B1 CLTC BACE2 SEC14L1 TTYH2 DENND4C TENM3 GPSM1 | 5.16e-07 | 195 | 283 | 10 | bd8e24dd598990204998d1dd853ba7a53dc0107e |
| ToppCell | normal-na-Hematopoietic-Progen-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.71e-06 | 173 | 283 | 9 | e666364eb110c1c976e5b09a632dd1454513f131 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-06 | 173 | 283 | 9 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-06 | 173 | 283 | 9 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-06 | 174 | 283 | 9 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-06 | 175 | 283 | 9 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-06 | 179 | 283 | 9 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 183 | 283 | 9 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.69e-06 | 190 | 283 | 9 | 1af91fe0ee2c924e12f4db93c793e7af475d8f80 | |
| ToppCell | Healthy_donor-CD4+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 4.38e-06 | 194 | 283 | 9 | a8a0368a4e0eb5654fdffc8a779b08ad402aa2eb | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.56e-06 | 195 | 283 | 9 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.76e-06 | 196 | 283 | 9 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_Naive|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.76e-06 | 196 | 283 | 9 | 58d6f7735631d8782f46ddd1eed3977713aedc55 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 4.76e-06 | 196 | 283 | 9 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-06 | 196 | 283 | 9 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 4.96e-06 | 197 | 283 | 9 | a97556e9fbb24272de51f54ecda6ab9ccb97a61e | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.16e-06 | 198 | 283 | 9 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-06 | 198 | 283 | 9 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.16e-06 | 198 | 283 | 9 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-06 | 198 | 283 | 9 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 5.38e-06 | 199 | 283 | 9 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 5.38e-06 | 199 | 283 | 9 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 5.38e-06 | 199 | 283 | 9 | 22a16381ad68e758aa8e44fa0d6d5a2335aa5fe3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 5.38e-06 | 199 | 283 | 9 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | CXCR5 BACE2 HS3ST1 RPS4Y2 PLEKHF2 DRAM2 FCRLA PARP14 PLEKHA2 | 5.60e-06 | 200 | 283 | 9 | 5c1b51b9571681d8b792d1443d9f8926dcd55b29 |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_T_naive|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.60e-06 | 200 | 283 | 9 | c1a0adaf2e4b099434557272f204cd36d6d84819 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 5.60e-06 | 200 | 283 | 9 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 5.60e-06 | 200 | 283 | 9 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | (23)_Follicular_B_cell|World / shred on Cell_type and subtype | 6.57e-06 | 204 | 283 | 9 | b92212322271740ed282b495c33f15455a9d758a | |
| ToppCell | droplet-Fat-Scat-21m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-06 | 161 | 283 | 8 | e52735f955f0a53da5cbe5a2d77a00484e5109b3 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 172 | 283 | 8 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 173 | 283 | 8 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-05 | 174 | 283 | 8 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-05 | 174 | 283 | 8 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 175 | 283 | 8 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 176 | 283 | 8 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-05 | 177 | 283 | 8 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-05 | 178 | 283 | 8 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 180 | 283 | 8 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 180 | 283 | 8 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 180 | 283 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 2.04e-05 | 180 | 283 | 8 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-05 | 131 | 283 | 7 | 1823cab28fab40486247ca92104267b1e370bdc1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-05 | 181 | 283 | 8 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 181 | 283 | 8 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.21e-05 | 182 | 283 | 8 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 182 | 283 | 8 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 2.29e-05 | 183 | 283 | 8 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 183 | 283 | 8 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.29e-05 | 183 | 283 | 8 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.29e-05 | 183 | 283 | 8 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 183 | 283 | 8 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 2.29e-05 | 183 | 283 | 8 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-05 | 184 | 283 | 8 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.39e-05 | 184 | 283 | 8 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.39e-05 | 184 | 283 | 8 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 185 | 283 | 8 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 185 | 283 | 8 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 185 | 283 | 8 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-05 | 186 | 283 | 8 | 77b09af860183606a1775eba921e2071e4a7dd4e | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.58e-05 | 186 | 283 | 8 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.58e-05 | 186 | 283 | 8 | f352c63666273defea3e57ba3a3bfad52c4ea65b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-05 | 186 | 283 | 8 | e2d265003aaea1acaf618d3f102c9933c19102e6 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 186 | 283 | 8 | 5fe11a5f9ff30f322ca88b44d592f241aabf397b | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 2.58e-05 | 186 | 283 | 8 | 9d339f57036d17572882ebb801f2be9b1d1ddc1c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.64e-05 | 136 | 283 | 7 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.68e-05 | 187 | 283 | 8 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-05 | 187 | 283 | 8 | e7970ec1507adfa91a296489166142cb9400421f | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.77e-05 | 137 | 283 | 7 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 188 | 283 | 8 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.78e-05 | 188 | 283 | 8 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-05 | 188 | 283 | 8 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 190 | 283 | 8 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 190 | 283 | 8 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 3.00e-05 | 190 | 283 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.00e-05 | 190 | 283 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.00e-05 | 190 | 283 | 8 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | wk_08-11-Epithelial-PNS-Early_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.00e-05 | 190 | 283 | 8 | 8190674a48607984726974765aafbca116f437e0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 190 | 283 | 8 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.11e-05 | 191 | 283 | 8 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | facs-Marrow-B-cells|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 191 | 283 | 8 | f84cd55e6fb112d271d35db11ad7648e03186e46 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.11e-05 | 191 | 283 | 8 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.11e-05 | 191 | 283 | 8 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-05 | 191 | 283 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-05 | 192 | 283 | 8 | 016a8cb8f7e74cba7270e3d1aa91589083663216 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-05 | 192 | 283 | 8 | 5a3c66fc3ae22bd9ac90ca137dee0bcabcd20ab8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.23e-05 | 192 | 283 | 8 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 3.23e-05 | 192 | 283 | 8 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-05 | 192 | 283 | 8 | 1f348e23843405abb1f1dc7d739fc5647333de16 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 3.35e-05 | 193 | 283 | 8 | 1778342a7f546dbc8c1f7875aa505345e72ee765 | |
| ToppCell | mild_COVID-19-CD4+_T_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.35e-05 | 193 | 283 | 8 | 40fc4a519c883c6c269a9c05be36ae906f75426a | |
| Computational | Neighborhood of PTPRD | 2.45e-05 | 58 | 162 | 7 | GCM_PTPRD | |
| Drug | Dantrolene-13C3 | RYR2 RYR3 PIK3C2A PYGB PYGL PYGM DMWD CACNA1A CACNA1E GRIN2A GRIN2B GRM1 CAMKK2 | 2.56e-08 | 145 | 276 | 13 | CID000002951 |
| Drug | Gvapspat amide | 6.86e-07 | 15 | 276 | 5 | CID000125015 | |
| Drug | AC1NBU2S | 1.66e-06 | 117 | 276 | 10 | CID004473765 | |
| Drug | 3,5-dimethylphenyl isocyanate | 1.76e-06 | 3 | 276 | 3 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 1.76e-06 | 3 | 276 | 3 | CID000147839 | |
| Drug | NSC758405 | 1.76e-06 | 3 | 276 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 1.76e-06 | 3 | 276 | 3 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 1.76e-06 | 3 | 276 | 3 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 1.76e-06 | 3 | 276 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 1.76e-06 | 3 | 276 | 3 | CID000191554 | |
| Drug | hydan | 1.76e-06 | 3 | 276 | 3 | CID000008360 | |
| Drug | EHMF | 1.76e-06 | 3 | 276 | 3 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 1.76e-06 | 3 | 276 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 1.76e-06 | 3 | 276 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 1.76e-06 | 3 | 276 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 1.76e-06 | 3 | 276 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 1.76e-06 | 3 | 276 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 1.76e-06 | 3 | 276 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 1.76e-06 | 3 | 276 | 3 | CID000446801 | |
| Drug | riboflavin tetraacetate | 1.76e-06 | 3 | 276 | 3 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 1.76e-06 | 3 | 276 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 1.76e-06 | 3 | 276 | 3 | CID000011459 | |
| Drug | Calcium | CCR9 TRPC5 ATP8B1 RYR2 RYR3 CXCR5 NEFM NRXN1 PYGL GNAS CACNA1A CACNA1E NPR1 HTR2B GRM1 PPP1CB CAMKK2 PPP3R1 P2RX3 MTOR | 2.82e-06 | 493 | 276 | 20 | ctd:D002118 |
| Drug | artemether | 3.37e-06 | 20 | 276 | 5 | CID000068911 | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | MRPL44 NCAPH2 KIF2A FGFR3 ALDH1B1 RGS3 SNIP1 CAMKK2 MTOR CENPI SMARCA2 KAT6B | 4.23e-06 | 192 | 276 | 12 | 6207_DN |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | KMT2B RPS4Y1 TRPC5 NCAPH2 FGFR3 ALDH1B1 DMWD PURG CCDC40 CUL3 LILRA2 GNA13 | 5.80e-06 | 198 | 276 | 12 | 4280_UP |
| Drug | D-myo-inositol-1,4,5-triphosphate | PLCXD2 INPP5A TRPC5 DGKA RYR2 RYR3 NOP9 PIK3C2A PYGB PYGL PYGM CACNA1A CACNA1E NPR1 ADAP1 CASQ2 GRM1 RGS3 PPP3R1 MTOR PRKACG | 6.68e-06 | 568 | 276 | 21 | CID000000806 |
| Drug | galocitabine | 6.99e-06 | 4 | 276 | 3 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 6.99e-06 | 4 | 276 | 3 | CID000135786 | |
| Drug | ingliforib | 6.99e-06 | 4 | 276 | 3 | CID006451325 | |
| Drug | uric acid riboside | 6.99e-06 | 4 | 276 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 6.99e-06 | 4 | 276 | 3 | CID000125259 | |
| Drug | pyridoxal diphosphate | 6.99e-06 | 4 | 276 | 3 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 6.99e-06 | 4 | 276 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 6.99e-06 | 4 | 276 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 6.99e-06 | 4 | 276 | 3 | CID000094262 | |
| Drug | Mem-CC | 6.99e-06 | 4 | 276 | 3 | CID003081269 | |
| Drug | SC 38249 | 6.99e-06 | 4 | 276 | 3 | CID000134834 | |
| Drug | BCIp4A | 6.99e-06 | 4 | 276 | 3 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 6.99e-06 | 4 | 276 | 3 | CID000097703 | |
| Drug | BCX-34 | 9.69e-06 | 12 | 276 | 4 | CID000060817 | |
| Drug | T0702 | 1.10e-05 | 25 | 276 | 5 | CID000005908 | |
| Drug | heptulose-2-P | 1.73e-05 | 5 | 276 | 3 | CID000124823 | |
| Drug | 6-FPLP | 1.73e-05 | 5 | 276 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 1.73e-05 | 5 | 276 | 3 | CID009576855 | |
| Drug | DHPBU | 1.73e-05 | 5 | 276 | 3 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 1.73e-05 | 5 | 276 | 3 | CID003080910 | |
| Drug | indirubin-5-sulphonate | 1.73e-05 | 5 | 276 | 3 | CID005288641 | |
| Drug | AC1LCUXJ | 1.73e-05 | 5 | 276 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 1.73e-05 | 5 | 276 | 3 | CID000080578 | |
| Drug | etafenone | 1.73e-05 | 5 | 276 | 3 | CID000003275 | |
| Drug | ddEtUrd | 1.73e-05 | 5 | 276 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 1.73e-05 | 5 | 276 | 3 | CID000125618 | |
| Drug | m-anisidine | 1.73e-05 | 5 | 276 | 3 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 1.73e-05 | 5 | 276 | 3 | CID000441028 | |
| Drug | 6-FDPL | 1.73e-05 | 5 | 276 | 3 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 1.73e-05 | 5 | 276 | 3 | CID003082179 | |
| Drug | GlcMan | 1.73e-05 | 5 | 276 | 3 | CID000152120 | |
| Drug | U66985 | 1.73e-05 | 5 | 276 | 3 | CID000127224 | |
| Drug | AC1O3M08 | 1.73e-05 | 5 | 276 | 3 | CID006331955 | |
| Drug | AC1L1DXE | TRPC5 RYR2 RYR3 PIK3C2A PYGB PYGL PYGM CACNA1A CACNA1E NDST2 GRIN2A GRIN2B P2RX3 MTOR | 1.89e-05 | 299 | 276 | 14 | CID000002548 |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | GART EHD1 KMT2A FLRT3 GNAS SEC14L1 GULP1 WNT7A TEAD1 RCAN3 PLEKHA2 | 1.98e-05 | 188 | 276 | 11 | 4545_DN |
| Drug | mercuric bromide | HEXA MYO1D RUNDC3B ATP8B1 NEFM NEFH TC2N ADAMTS20 PYGM TACC1 DCLK2 GNAS PDGFC HS3ST1 PCDH18 ARAP2 GULP1 CUL3 COL12A1 MAN1C1 HTATIP2 GRIN2A SIX1 TTLL6 EPHA2 SMARCA2 KNDC1 SV2C PLEKHA2 ULK2 | 2.03e-05 | 1076 | 276 | 30 | ctd:C042720 |
| Drug | DL-PPMP; Down 200; 2uM; MCF7; HT_HG-U133A_EA | VWA8 INPP5A NOL6 KIF2A SEC14L1 AMPD2 CASD1 PPP3R1 CENPI NEIL3 KAT6B | 2.77e-05 | 195 | 276 | 11 | 1121_DN |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | RPS4Y1 CPED1 PVR EHD1 ATP11A CMKLR2 LILRA2 SRSF5 TENM4 TENM3 PRKACG | 3.05e-05 | 197 | 276 | 11 | 2759_UP |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | KMT2B PVR MLLT3 ELOVL6 CHST10 DDX52 HTATIP2 SIX1 SNIP1 MTOR EPHA2 | 3.05e-05 | 197 | 276 | 11 | 2763_DN |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | VWA8 DGKA NCAPH2 EHD1 PYGB DMWD TPST1 CPT2 DENND4C DECR2 SNX1 | 3.19e-05 | 198 | 276 | 11 | 6271_DN |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; MCF7; HT_HG-U133A | MRPL44 GART ASH1L FLRT3 CMKLR2 CHST10 SRSF5 SNIP1 EPHA2 ULK2 SIX2 | 3.19e-05 | 198 | 276 | 11 | 7513_UP |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | INPP5A NCAPH2 AKAP7 SEC14L1 CHST10 DDX52 OVGP1 MTOR EPHA2 HYI SIX2 | 3.34e-05 | 199 | 276 | 11 | 6836_DN |
| Drug | 5-methylthioribose-1-phosphate | 3.43e-05 | 16 | 276 | 4 | CID000000465 | |
| Drug | butylethanolamine | 3.43e-05 | 16 | 276 | 4 | CID000249006 | |
| Drug | norstatine | 3.43e-05 | 6 | 276 | 3 | CID000173844 | |
| Drug | CV-araU | 3.43e-05 | 6 | 276 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 3.43e-05 | 6 | 276 | 3 | CID003005944 | |
| Drug | benzothiadiazole | 3.43e-05 | 6 | 276 | 3 | CID000086412 | |
| Drug | Carbocyclic Bvdc | 3.43e-05 | 6 | 276 | 3 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 3.43e-05 | 6 | 276 | 3 | CID000152984 | |
| Drug | EdUMP | 3.43e-05 | 6 | 276 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 3.43e-05 | 6 | 276 | 3 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 3.43e-05 | 6 | 276 | 3 | CID000656428 | |
| Drug | AzddCyd | 3.43e-05 | 6 | 276 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 3.43e-05 | 6 | 276 | 3 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 3.43e-05 | 6 | 276 | 3 | CID006439191 | |
| Drug | DNPP | 3.43e-05 | 6 | 276 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 3.43e-05 | 6 | 276 | 3 | CID000082693 | |
| Drug | NSC-97433 | 3.43e-05 | 6 | 276 | 3 | CID000001803 | |
| Drug | tetra-N-acetylchitotetraose | 3.43e-05 | 6 | 276 | 3 | CID003081988 | |
| Drug | AR-L57 | 3.43e-05 | 6 | 276 | 3 | CID000156890 | |
| Drug | 4-methylumbelliferone | 3.43e-05 | 132 | 276 | 9 | CID003364573 | |
| Drug | [(4E)-4-[(2,2-difluoroethylamino)methylene]-6-methyl-5-oxo-3-pyridyl]methyl dihydrogen phosphate | 4.44e-05 | 17 | 276 | 4 | CID011840958 | |
| Drug | BAPTA | TRPC5 GARS1 RYR2 RYR3 SACS CACNA1A CMKLR2 CACNA1E GRIN2A GRIN2B GRM1 CAMKK2 PPP3R1 PRKACG | 4.56e-05 | 324 | 276 | 14 | CID000104751 |
| Drug | 8-azido cyclic AMP | 5.66e-05 | 18 | 276 | 4 | CID000115296 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 5.95e-05 | 7 | 276 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 5.95e-05 | 7 | 276 | 3 | CID003080803 | |
| Drug | AC1L3372 | 5.95e-05 | 7 | 276 | 3 | CID000108025 | |
| Drug | 1 Gpt | 5.95e-05 | 7 | 276 | 3 | CID000101247 | |
| Drug | formycins | 5.95e-05 | 7 | 276 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 5.95e-05 | 7 | 276 | 3 | CID000161214 | |
| Drug | hydantocidin | 5.95e-05 | 7 | 276 | 3 | CID000125429 | |
| Drug | Feruloyl Coenzyme A | 5.95e-05 | 7 | 276 | 3 | CID000656999 | |
| Disease | Epileptic encephalopathy | 1.51e-04 | 30 | 268 | 4 | C0543888 | |
| Disease | Cakut | 1.98e-04 | 13 | 268 | 3 | C1968949 | |
| Disease | Catecholaminergic polymorphic ventricular tachycardia 1 | 2.45e-04 | 3 | 268 | 2 | cv:C1631597 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY | 2.45e-04 | 3 | 268 | 2 | 604772 | |
| Disease | Endocrine System Diseases | 2.45e-04 | 3 | 268 | 2 | C0014130 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.45e-04 | 3 | 268 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.45e-04 | 3 | 268 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.45e-04 | 3 | 268 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | triacylglycerol 52:5 measurement | 2.79e-04 | 35 | 268 | 4 | EFO_0010417 | |
| Disease | Benign neoplasm of bladder | 3.11e-04 | 15 | 268 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.11e-04 | 15 | 268 | 3 | C0154091 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.11e-04 | 15 | 268 | 3 | C0496930 | |
| Disease | gliosarcoma | 3.80e-04 | 16 | 268 | 3 | C0206726 | |
| Disease | cyclic adenosine monophosphate measurement | 4.58e-04 | 17 | 268 | 3 | EFO_0010473 | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 4.87e-04 | 4 | 268 | 2 | C4551898 | |
| Disease | migraine (implicated_via_orthology) | 4.87e-04 | 4 | 268 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Stress-induced polymorphic ventricular tachycardia | 4.87e-04 | 4 | 268 | 2 | C2677794 | |
| Disease | Carcinoma, Transitional Cell | 5.17e-04 | 41 | 268 | 4 | C0007138 | |
| Disease | Child Behaviour Checklist assessment | 5.46e-04 | 18 | 268 | 3 | EFO_0005661 | |
| Disease | Carcinoma of bladder | 5.46e-04 | 18 | 268 | 3 | C0699885 | |
| Disease | obsolete_red blood cell distribution width | KMT2B MYO1D GARS1 BACE1 NCAPH2 PICALM LONP1 VPS33B EIF3L ATP11A CUL3 LARP1 BUD13 MAU2 SIPA1 APLF DENND4C ARSG ESYT3 LOXHD1 G3BP1 OR10K1 SMARCA2 SV2C GPSM1 | 6.11e-04 | 1347 | 268 | 25 | EFO_0005192 |
| Disease | cognitive function measurement | GBF1 TCERG1L BRINP1 ATP8B1 PLA2G15 RYR3 PTPRD PTPRF NRXN1 SRGAP1 TACC1 BACE2 PURG CUL3 CACNA1E CEP192 GRIN2A GRIN2B TEAD1 RGS3 LRIG3 TENM4 PPP3R1 RERGL PLEKHA1 AFG1L | 6.71e-04 | 1434 | 268 | 26 | EFO_0008354 |
| Disease | CCL4 measurement | 7.53e-04 | 20 | 268 | 3 | EFO_0004751 | |
| Disease | Familial ventricular tachycardia | 8.07e-04 | 5 | 268 | 2 | C0340485 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement | 8.07e-04 | 5 | 268 | 2 | EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Intellectual Disability | HEXA ASH1L NRXN1 SACS FDFT1 GNAS CACNA1E PTPN23 ARMC9 GRIN2B MTOR STAG2 | 8.68e-04 | 447 | 268 | 12 | C3714756 |
| Disease | gestational age, birth measurement | 8.73e-04 | 21 | 268 | 3 | EFO_0005112, EFO_0006921 | |
| Disease | Schizophrenia | MYO5B INPP5A NPAS3 BACE1 PTPN1 NRXN1 UFD1 KMT2A KIF2A GNAS GRIN2A GRIN2B GRM1 CAMKK2 TENM4 PPP3R1 MTOR SMARCA2 | 1.28e-03 | 883 | 268 | 18 | C0036341 |
| Disease | temperament and character inventory | 1.30e-03 | 24 | 268 | 3 | EFO_0004825 | |
| Disease | Noonan Syndrome | 1.30e-03 | 24 | 268 | 3 | C0028326 | |
| Disease | heel bone mineral density, urate measurement | 1.43e-03 | 182 | 268 | 7 | EFO_0004531, EFO_0009270 | |
| Disease | amino acid measurement | MYH10 EXD1 NCAPH2 CHIT1 RYR2 RYR3 AXIN2 PDGFC LARP1 BUD13 FASTKD2 GRIN2B GRM1 TENM4 RERGL | 1.47e-03 | 678 | 268 | 15 | EFO_0005134 |
| Disease | progressive familial intrahepatic cholestasis (is_implicated_in) | 1.67e-03 | 7 | 268 | 2 | DOID:0070221 (is_implicated_in) | |
| Disease | orofacial cleft (is_implicated_in) | 1.67e-03 | 7 | 268 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.67e-03 | 7 | 268 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Tourette syndrome, bipolar disorder | 1.67e-03 | 7 | 268 | 2 | EFO_0004895, MONDO_0004985 | |
| Disease | Hypertensive disease | 1.83e-03 | 190 | 268 | 7 | C0020538 | |
| Disease | azoospermia (implicated_via_orthology) | 1.84e-03 | 27 | 268 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | household income | 1.96e-03 | 304 | 268 | 9 | EFO_0009695 | |
| Disease | Alzheimer disease, educational attainment | 1.99e-03 | 247 | 268 | 8 | EFO_0011015, MONDO_0004975 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 2.05e-03 | 28 | 268 | 3 | DOID:0050866 (is_implicated_in) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.05e-03 | 28 | 268 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | response to antineoplastic agent | 2.13e-03 | 99 | 268 | 5 | GO_0097327 | |
| Disease | mean arterial pressure | EXD1 INPP5A CASZ1 PTPRD KIF2A GNAS ABCC10 ENOSF1 NPR1 ATG7 SIPA1 HYI | 2.19e-03 | 499 | 268 | 12 | EFO_0006340 |
| Disease | cognitive disorder (biomarker_via_orthology) | 2.22e-03 | 8 | 268 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | cleft palate (implicated_via_orthology) | 2.22e-03 | 8 | 268 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | Posterior subcapsular cataract | 2.22e-03 | 8 | 268 | 2 | C0858617 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 2.22e-03 | 8 | 268 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | bipolar disorder (is_implicated_in) | 2.27e-03 | 29 | 268 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.73e-03 | 152 | 268 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | NCAPH2 CPED1 CMC2 PTPN1 LONP1 PTPRF FDFT1 MLLT3 ABCC10 AKAP7 DRAM2 MAU2 MTOR OTUD4 STAG2 XPO7 | 2.81e-03 | 799 | 268 | 16 | EFO_0010701 |
| Disease | cortical thickness | KMT2B EXD1 NBEAL1 SMARCAD1 CPED1 PTPRF ADAMTS20 KMT2A PYGB TACC1 FGFR3 PDGFC ABCC10 COL12A1 WNT7A SRGAP2 G3BP1 GNA13 RASL11B ULK2 | 3.08e-03 | 1113 | 268 | 20 | EFO_0004840 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.20e-03 | 157 | 268 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | Malignant mesothelioma | 3.23e-03 | 109 | 268 | 5 | C0345967 | |
| Disease | cardiovascular disease | EXD1 INPP5A BACE1 CASZ1 CCR7 PCDH18 ABCC10 NPR1 ATG7 THAP9 EPHA2 | 3.28e-03 | 457 | 268 | 11 | EFO_0000319 |
| Disease | schizophrenia (implicated_via_orthology) | 3.44e-03 | 68 | 268 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | Asthma, Occupational | 3.52e-03 | 10 | 268 | 2 | C0264423 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 3.52e-03 | 10 | 268 | 2 | C1631597 | |
| Disease | triacylglycerol 58:8 measurement | 3.91e-03 | 35 | 268 | 3 | EFO_0010442 | |
| Disease | Semantic-Pragmatic Disorder | 4.28e-03 | 11 | 268 | 2 | C0454655 | |
| Disease | endometrial carcinoma, endometriosis | 4.28e-03 | 11 | 268 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | Auditory Processing Disorder, Central | 4.28e-03 | 11 | 268 | 2 | C0751257 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 4.28e-03 | 11 | 268 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | chronic kidney disease, Proteinuria | 4.28e-03 | 11 | 268 | 2 | EFO_0003884, HP_0000093 | |
| Disease | Language Delay | 4.28e-03 | 11 | 268 | 2 | C0023012 | |
| Disease | Language Development Disorders | 4.28e-03 | 11 | 268 | 2 | C0023014 | |
| Disease | vascular dementia (is_marker_for) | 4.28e-03 | 11 | 268 | 2 | DOID:8725 (is_marker_for) | |
| Disease | glycerophosphorylcholine measurement | 4.28e-03 | 11 | 268 | 2 | EFO_0020018 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 4.28e-03 | 11 | 268 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Tachycardia, Ventricular | 4.28e-03 | 11 | 268 | 2 | C0042514 | |
| Disease | Speech Delay | 4.28e-03 | 11 | 268 | 2 | C0241210 | |
| Disease | pulse pressure measurement | NBEAL1 INPP5A RPS15 AHDC1 CASZ1 PTPRD PIK3C2A PDGFC ABCC10 KLB TBXAS1 ATG7 WNT7A OTUB1 WNT9B CASQ2 SIPA1 DENND4C LRIG3 TENM4 PPP3R1 TTLL6 HHIPL1 | 4.35e-03 | 1392 | 268 | 23 | EFO_0005763 |
| Disease | serum gamma-glutamyl transferase measurement | PIK3AP1 ASH1L ATP8B1 RYR2 CYP2W1 KMT2A MLLT3 ARAP2 KLB TWNK FCRLA CAMKK2 TENM4 EPHA2 PIWIL3 SPATA13 AFG1L | 4.41e-03 | 914 | 268 | 17 | EFO_0004532 |
| Disease | osteoarthritis, hand | 4.58e-03 | 37 | 268 | 3 | EFO_1000789 | |
| Disease | monocyte count | PIK3AP1 ASH1L NAP1L4 JAML DDB2 AHDC1 CASZ1 EHD3 PTPN1 FDFT1 ALDH1B1 ELOVL6 PDGFC TBXAS1 TTF2 ZYG11B ARMC9 APLF SV2C PLEKHA2 HYI TGS1 | 4.75e-03 | 1320 | 268 | 22 | EFO_0005091 |
| Disease | neuritic plaque measurement | CYP2B6 NPAS3 RYR3 ALDH1B1 HS3ST1 AKAP7 CACNA1A SMARCA2 SPATA13 | 4.87e-03 | 349 | 268 | 9 | EFO_0006798 |
| Disease | myocardial infarction | 4.96e-03 | 350 | 268 | 9 | EFO_0000612 | |
| Disease | Dental enamel hypoplasia | 5.11e-03 | 12 | 268 | 2 | EFO_1001304 | |
| Disease | ovarian reserve | 5.11e-03 | 12 | 268 | 2 | EFO_0004770 | |
| Disease | Colorectal Carcinoma | TCERG1L BRINP1 AXIN2 FAT1 PTPRD SACS FGFR3 GNAS SRSF6 GRIN2A GRM1 OVGP1 PANK4 SNRPB2 | 5.24e-03 | 702 | 268 | 14 | C0009402 |
| Disease | lactate measurement | 5.32e-03 | 39 | 268 | 3 | EFO_0007745 | |
| Disease | migraine disorder | 5.62e-03 | 357 | 268 | 9 | MONDO_0005277 | |
| Disease | mood disorder | 6.00e-03 | 13 | 268 | 2 | EFO_0004247 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 6.00e-03 | 13 | 268 | 2 | EFO_0800413 | |
| Disease | Hodgkins lymphoma | 6.69e-03 | 82 | 268 | 4 | EFO_0000183 | |
| Disease | S-6-hydroxywarfarin measurement | 6.81e-03 | 368 | 268 | 9 | EFO_0803326 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 6.96e-03 | 14 | 268 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | unipolar depression, anxiety | 6.96e-03 | 14 | 268 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | 5-methyluridine (ribothymidine) measurement | 6.96e-03 | 14 | 268 | 2 | EFO_0020013 | |
| Disease | dystonia (is_implicated_in) | 6.96e-03 | 14 | 268 | 2 | DOID:543 (is_implicated_in) | |
| Disease | Malformations of Cortical Development | 6.96e-03 | 14 | 268 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 6.96e-03 | 14 | 268 | 2 | C0431380 | |
| Disease | Testicular Germ Cell Tumor | 6.96e-03 | 14 | 268 | 2 | C1336708 | |
| Disease | Liver carcinoma | CYP2B6 KMT2B AXIN2 EHD3 FDFT1 KMT2A PYGL ATG7 HTATIP2 MTOR NEIL3 | 7.02e-03 | 507 | 268 | 11 | C2239176 |
| Disease | Alzheimer's disease (is_implicated_in) | 7.23e-03 | 132 | 268 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | Giant Cell Glioblastoma | 7.27e-03 | 84 | 268 | 4 | C0334588 | |
| Disease | melanoma | 7.81e-03 | 248 | 268 | 7 | C0025202 | |
| Disease | Dystonia | 7.89e-03 | 86 | 268 | 4 | C0013421 | |
| Disease | Malignant neoplasm of salivary gland | 7.94e-03 | 45 | 268 | 3 | C0220636 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 7.98e-03 | 15 | 268 | 2 | EFO_0004847, MONDO_0004976 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFRRYENLKGVLEGF | 691 | O75410 | |
| RKVTIAGFDLNSYRD | 196 | O60507 | |
| RSLFLFSEDNVVRKY | 76 | O00555 | |
| ARFQIGKRKYDFDSS | 26 | Q9Y2R4 | |
| FDYLNGEYRAKKLSR | 461 | A0FGR9 | |
| LSAAYRFVLTEGQKR | 46 | Q8NFU1 | |
| RFVLTEGQKRYFEKL | 51 | Q8NFU1 | |
| FQYAETVFRDKSGRK | 456 | Q9BRD0 | |
| GFYVVFDRARKRIGF | 401 | P56817 | |
| YVIFDRAQKRVGFAA | 416 | Q9Y5Z0 | |
| TLFNKTFRDAFGRYI | 381 | P41595 | |
| FFVSGKYLRQKRIDF | 2036 | Q9NR48 | |
| LEVFGYRDHNVRKAF | 21 | Q4VNC0 | |
| LRFREKYGDVFTVHL | 56 | P20813 | |
| RLQTFIRAIFYVGKG | 476 | Q8NAG6 | |
| GDSFSLLVDKYIFRI | 86 | Q8IW19 | |
| HYGRDSFVRLLLEFK | 126 | Q9H672 | |
| LYTFAGVKFRSDLSR | 321 | P32302 | |
| INGVLYIKSFRGFIR | 301 | Q5SY80 | |
| YTSLGKVQFFIERER | 896 | A6NCI8 | |
| VLKVIAFGFLNYFRD | 1526 | Q15878 | |
| KEFLNRFYKSLIDRG | 41 | Q49AH0 | |
| RFYKSLIDRGVNFSL | 46 | Q49AH0 | |
| REDEYRFTKLLQIAG | 231 | O76031 | |
| SEIFQRLYRSDVFKG | 421 | A4D0V7 | |
| QVFGYSLRFNADLLR | 656 | O60477 | |
| RRAANGFKYFTKREE | 1271 | Q86V15 | |
| KFISHRFGEEILYRI | 246 | Q9P0M2 | |
| RKVRFDYDLFLHLEG | 96 | P42568 | |
| RYGLAAAVFTRDLDK | 441 | P30837 | |
| EEGAFRDSNYLRLLF | 146 | Q9NZU0 | |
| KFYGETEAKLRQIFA | 426 | Q8NB90 | |
| YNIEAEGLFSKLFSR | 111 | Q8WV93 | |
| QGRRFITLIDNFYDL | 386 | Q8WV93 | |
| YAFIGVKFRNDLFKL | 326 | P32248 | |
| TSVIKFLRQYEFDGL | 121 | Q9BZP6 | |
| SNITFALLFGRRFDY | 176 | Q8TAV3 | |
| FVDARALARKFITLY | 2036 | Q96DT5 | |
| GAYLFRTFLEREKCV | 91 | Q9Y2T1 | |
| EFGALQTVRLERYKA | 416 | Q96EG1 | |
| KYIFKERESFDGRNI | 331 | Q8N9N2 | |
| AVKVQYIDLRDRFDG | 226 | Q3MIX3 | |
| FVLTEREGALKYFNR | 151 | O75689 | |
| LSGNKFQDRYFVLRD | 1451 | Q8WZ64 | |
| LAKRLGDETYFSFLR | 596 | Q8N6M6 | |
| GDKEQKLRFAFRIYD | 86 | P63098 | |
| FGLREFSQIRYDAVK | 31 | Q9P0S2 | |
| ERQNLFTGYFRSLLD | 831 | Q5TGY3 | |
| RLFDVYRTKGQLANF | 576 | Q01433 | |
| RFVLKITDYGLESFR | 671 | P16066 | |
| KHGFRDLRQFIDEYV | 381 | Q6ZUJ8 | |
| EIKSQFRTREGFYKL | 21 | Q09019 | |
| VGQRDLLFNYKRFFV | 1021 | O43520 | |
| GRKYREVFCIDQFQR | 1436 | P59510 | |
| EIKISAADYAQFRGR | 66 | Q9H0I3 | |
| RHLLVLRKGNFYIFD | 241 | P23786 | |
| LRKGNFYIFDVLDQD | 246 | P23786 | |
| KLREFCRENYGLEFQ | 66 | Q9ULI1 | |
| DSRRVFRKKYGVQFL | 1031 | Q6ZS30 | |
| AREQKERFEALFTIY | 61 | Q9UKA8 | |
| YKQTIGLDFFLRRIT | 41 | P51157 | |
| YLRENREKFEAFIEG | 71 | Q01804 | |
| TLRDYRKFFQDIGFE | 291 | Q8NCC3 | |
| KYGLAVFQAFLRTEF | 1081 | P49796 | |
| EVQVRGSLDFEKYRF | 301 | Q9Y5H2 | |
| FGERVAYFQSALDKL | 266 | Q9H3S7 | |
| FFNIEVRTRTDGAKY | 181 | Q9HCL0 | |
| IYRRKDLSVFEVDGN | 781 | Q8WYB5 | |
| DRFVLYKEGERDFLQ | 251 | Q8N149 | |
| RGYLRVFFRTNDAKV | 21 | Q9UI09 | |
| KGNQIRIRFVSDEYF | 136 | Q9NRA1 | |
| NSAIRFLRKYSFDGL | 121 | Q13231 | |
| AKDRFYINERGQIFT | 2536 | Q14517 | |
| RDVDLYGRAADKFLS | 441 | Q8N612 | |
| RFIVDYSRGLEAFQF | 56 | Q08AI8 | |
| RDNILFGKTFDAQLY | 681 | Q5T3U5 | |
| AALYQPLFDKRREFI | 96 | Q99733 | |
| LRSLDYEALQGFQFR | 516 | Q9Y5F0 | |
| LQEYLGKFRRLEDFR | 1011 | Q6PKG0 | |
| ALGYFRRALSALKEA | 61 | Q86U38 | |
| QLRFSYLAVIEGAKF | 266 | P18031 | |
| FRAKFDPRVLARYDI | 51 | Q96QS6 | |
| AEGFVRVDRDYVLKS | 101 | Q9BUP3 | |
| NCFIDRDGKVFRYIL | 46 | Q4G0X4 | |
| RDGKVFRYILNFLRT | 51 | Q4G0X4 | |
| RQLFRIEGVKSVFFG | 101 | Q9UMS0 | |
| RDFSILFYRCRKAGL | 226 | Q8TAT5 | |
| FLRVLFGFLYRKTDF | 26 | Q8IVD9 | |
| LGFAYAVRAVKRAEF | 716 | Q96JK4 | |
| LRLREVEFASEGKYQ | 566 | Q6UXM1 | |
| ADTKVARRYGDFFIR | 531 | Q9Y262 | |
| FYERNLSLVKELGDR | 191 | Q86YR5 | |
| FRGRDFVIQVLDKYN | 4736 | O95714 | |
| AFVERVRKQGFEVVY | 371 | Q58FF7 | |
| AFLARFKERVGYREG | 16 | Q96AT1 | |
| IRDGDSFAQKLEFYL | 86 | Q7Z3E5 | |
| RVYLFDIFLLGSRAF | 126 | Q8NHP7 | |
| KEERLRSFYQGEKNF | 311 | Q6UWP7 | |
| LVSDNNLKDYFERGR | 721 | Q8IVV2 | |
| DRYFKGLVFAISSDR | 81 | Q8N568 | |
| EEFYNLVRFRIGGKR | 11 | P37268 | |
| LKDIVGDFRGFYRQL | 81 | Q7L5Y1 | |
| RIIDQRFEKVSYFVF | 216 | Q14642 | |
| YSFRQDGRIKEVSVF | 1416 | O00443 | |
| IYSEFRKNFETLRID | 71 | Q9BVG4 | |
| TYKFAEEIRRQSFGA | 66 | P41247 | |
| GFFLTYIRDFQKISL | 221 | Q6UX65 | |
| LEIVYKSFDFSNVLR | 166 | O95843 | |
| VLKDGFVFRIRVAYQ | 786 | Q9H6R4 | |
| TFNVSRVLYEKFFRD | 141 | Q9NUI1 | |
| EFTFKLYDTDRNGIL | 116 | P23743 | |
| KESARIAYTFARAFL | 811 | P36776 | |
| VYVDFEGINFKRKFL | 1706 | Q9UMN6 | |
| RIAAQDYIIGVFRKF | 531 | Q96RR1 | |
| VLYIDRFLGGVFSKR | 211 | Q9NQV6 | |
| AYDRRREFQLGESVK | 161 | Q14344 | |
| REFQLGESVKYFLDN | 166 | Q14344 | |
| FQLKTRSARGLVLYF | 56 | Q9ULB1 | |
| DLRQVRGKASFLYSL | 271 | Q92466 | |
| FGLTEFQRKTQYLFE | 291 | O60243 | |
| ANLILIYGNEFDKRF | 286 | Q9UHF4 | |
| LRSLDYEALQGFQFR | 516 | Q9Y5F1 | |
| RLGGRLFSVIFKYEV | 756 | Q9NVE7 | |
| EDGYEFFAKRQLVTL | 251 | P62140 | |
| DKARFYQSEIKRLFG | 756 | Q460N5 | |
| FFEIYSGKVFDLLNR | 366 | O00139 | |
| DRFAGYIDKVRQLEA | 106 | P12036 | |
| RLLTSGYLQRESKFF | 176 | Q96FW1 | |
| DIILFRDRFDGYVFL | 106 | Q9BZI7 | |
| GCVRALAKIERFEFY | 106 | A2VDF0 | |
| DDIRLYQKDFLRIAG | 546 | Q96NE9 | |
| YALRAAGFRVSRKFA | 181 | Q9H5J4 | |
| RRNILYKTIFEGFAK | 656 | O60308 | |
| FREGLEQAVRYAKAL | 86 | Q5T013 | |
| QFFLSGLERGTKRRY | 341 | Q14674 | |
| VGGLIERQKYFFRIR | 861 | Q8N9C0 | |
| VNEFLAKARGDFLYR | 16 | P22612 | |
| SKVLDQYEREGFNFL | 651 | O95352 | |
| IGDSRIRQLFYSFVK | 91 | Q96PB1 | |
| TRKEYFIFLELATGR | 91 | Q8NCB2 | |
| VGRNNFKYILDFIAA | 151 | Q99715 | |
| SAARLLFSFYKDGRI | 201 | Q7L513 | |
| LKFFGYCNDVDRELR | 31 | Q9NRP2 | |
| LKDFFQSYGNVVELR | 356 | Q13283 | |
| VYRGEAERIFIELKF | 86 | P29317 | |
| YIQGLLDLKSRFDRF | 341 | Q13618 | |
| RFVLKVTDYGFNDIL | 681 | P51841 | |
| IGQAFDLAYRKFLES | 141 | Q9UBP9 | |
| QAVKEGRYVFLFRSK | 1076 | Q4G0X9 | |
| GRYVFLFRSKQSLVL | 1081 | Q4G0X9 | |
| LYVFVGERFRRDLVK | 316 | P51686 | |
| VLAHKGYFREARDVF | 656 | Q6PD62 | |
| RQGFLKSRDRAYAKF | 601 | Q5VZ89 | |
| AFYLTGEEVFRIKAI | 271 | Q9NR34 | |
| YLRLSLGEFFAQRSE | 576 | Q8TEP8 | |
| EDQARFYFQDLIKGI | 286 | Q96RR4 | |
| FSFQGLRLDEALRLY | 771 | Q92538 | |
| RGLFYVDFNSKQKER | 476 | Q86Z14 | |
| RVFVDFEGISLRRKF | 1996 | Q03164 | |
| FGLTEFQRKTQYLFE | 431 | Q96MM7 | |
| YLKQRIARFSGADIS | 1701 | Q76NI1 | |
| QAFERIEDYIKLIGF | 156 | O14958 | |
| RLLLQERGKAAEFYS | 6 | Q8TB33 | |
| IRSFFARYGSVKEVK | 56 | Q92904 | |
| EYAAKGNLREFLRAR | 556 | P22607 | |
| DRKEQINLLYGFFFA | 176 | Q92674 | |
| IYSNAGEKSFDRLLR | 261 | Q13255 | |
| EGIDRYKHFARFLLE | 1056 | Q8IY37 | |
| RFLLEGQVFRKLASY | 1066 | Q8IY37 | |
| RVQIEEFAKRFYSEG | 1191 | Q8IVF4 | |
| EKQRISRGYDFAAVL | 161 | Q9H4M9 | |
| RTFKLLDFEQVGRNY | 231 | Q7Z3Z3 | |
| EELKRSLYALFSQFG | 21 | P08579 | |
| FIDDNTRRKFLIYAG | 451 | Q92503 | |
| RRDVGSAAFKIFLKY | 2001 | Q9NZJ4 | |
| FQGRYNEAKRFLRET | 471 | Q9Y6X3 | |
| TGERFRIFRAEKTYA | 1081 | Q92736 | |
| YRIGQSKIFFRAGVL | 761 | P35580 | |
| YFSVENLERDFFLRG | 226 | Q659C4 | |
| SYGLEKKFRREIFQD | 781 | Q659C4 | |
| GSEYRTLLKAFGIRF | 291 | P56373 | |
| KARQFFLFNDILVYG | 51 | Q9H8W4 | |
| QYILREFKVTDARDG | 1776 | P10586 | |
| YDVRFLGRLLDFINV | 196 | Q12889 | |
| QYILREFKVTDARDG | 1781 | P23468 | |
| RFYLDVKQSSRGRFL | 71 | Q9UJV8 | |
| EFKSALRRTIGQTFY | 296 | Q8NGX5 | |
| LEEASRLYFGERNVK | 2031 | P42345 | |
| LDEAFQRYRDLLFGS | 61 | P06865 | |
| EFLVRDGRLNVDYKA | 176 | O14792 | |
| AGYASRFIVIADFRK | 186 | P49247 | |
| IFGQLRDFYFSVKLS | 116 | Q9NY12 | |
| YSESKRLEFVAARLG | 86 | P15151 | |
| FKTTRRFYEDGAIVL | 166 | Q96NL0 | |
| VRFLTKRFIGDYERN | 51 | Q9BPW5 | |
| NSGKFLRRYFILDTQ | 21 | Q9HB19 | |
| RDHRKIGRDQELYFF | 321 | P26639 | |
| LIEFIRSEYRKRGFQ | 356 | P26639 | |
| YSQGVKLFRFDAEVR | 1061 | Q7Z3J3 | |
| AARVALRKLYGFTEN | 296 | Q9H9J2 | |
| SSEEKFLRRIGRFGY | 21 | P02808 | |
| FFDFIGRYSRRQSKK | 451 | Q8IYL2 | |
| DVLKFGFSSREYVLL | 356 | Q8TAD8 | |
| IEAIAKFDYVGRSAR | 746 | Q7Z6B7 | |
| KFDYVGRSARELSFK | 751 | Q7Z6B7 | |
| TVFSYFAEVLAREKR | 261 | Q496J9 | |
| LTLQRKREEYFGFIE | 236 | Q9NU19 | |
| SFAFAKALIYRIREP | 91 | Q9H628 | |
| FAFRNFLYLRLDGTT | 1086 | P51531 | |
| LYVDSLFFLRGRLDQ | 301 | P78395 | |
| LFRRLKLNYAIFDEG | 616 | Q9H4L7 | |
| ASLINEFKLYSVFRG | 146 | Q9NYW6 | |
| EFKLYSVFRGIEATR | 151 | Q9NYW6 | |
| ERDFGRLNVKLFYNS | 221 | Q8N9U0 | |
| FSDSLRRELSYFGVK | 186 | O75452 | |
| VLYSQGVKLFRFDAE | 1051 | P0DJD1 | |
| IFSGRRAKEEIVFRY | 171 | Q86YT9 | |
| TDIIRYLFQDAFIFK | 71 | Q9NYY8 | |
| KYFIRDEFLRISTAS | 981 | Q5JWF2 | |
| ADYNVIKRIESGAFR | 156 | O94933 | |
| DTLKRRFFYDQAFAI | 126 | P41250 | |
| LGNYERFLDIRLTKD | 71 | P17812 | |
| RIYAQKFIDRGKDFN | 416 | P30876 | |
| VRLKGFESYRAQLDT | 371 | Q96FS4 | |
| VFLRNRLKYALTGDE | 46 | P22090 | |
| VFLRNRLKYALTGDE | 46 | Q8TD47 | |
| VAFHRGNFRELYKIL | 56 | Q15475 | |
| RSRRGKENFEFYELA | 61 | Q8IXF0 | |
| QRATEGRKEELFALY | 361 | Q8TE99 | |
| IRKGDIFIVYDTRFV | 371 | P49221 | |
| IFLRNRLKYALTGDE | 46 | P62701 | |
| KDIQRFFSGYGRLLE | 16 | Q13247 | |
| HIFFRDRYGTKQREL | 156 | B9A6J9 | |
| EKQRISRGYDFAAVL | 161 | Q9NZN3 | |
| EKERFFNYCGLERAL | 161 | Q8TAY7 | |
| REKDVERFFKGYGRI | 16 | Q13243 | |
| ERFFKGYGRIRDIDL | 21 | Q13243 | |
| FQARFRSSVAEILKY | 311 | P46091 | |
| EFRRIAAYLFKGNNR | 1506 | Q00610 | |
| DIRRLYARFEGDFKL | 331 | O43529 | |
| LERLLSAYRNKFGEI | 216 | Q8NCH0 | |
| SLVYQALDFISGKRR | 76 | Q6IBW4 | |
| EGVQRLGFTYLRLKD | 516 | P98196 | |
| EFLSRLNYFLKDEGR | 101 | Q96PV4 | |
| FKDAIRLFAAYNEGI | 201 | Q13492 | |
| FGNIEDIYKFQRKFL | 286 | Q96N96 | |
| FAEKYGRDQRFRLVQ | 541 | Q5VWI1 | |
| TFRKFTYRGVDLDQL | 11 | P62841 | |
| LKRYAESGDAFDIQR | 166 | P24557 | |
| QIAEALKRYSERAFF | 326 | Q9C0D3 | |
| FRSAEKLALFLRVYE | 216 | Q9NUD5 | |
| FFEGKELRLKQEYFV | 286 | P11217 | |
| FAVKRRFSDFLGLYE | 181 | Q13596 | |
| FQESDFESYGIRRKL | 66 | Q9H5L6 | |
| HIFFRDRYGTKQREL | 156 | A6NER0 | |
| TFREQLEAGIRYFDL | 101 | Q0VAA5 | |
| VAAGEFLYKKLFSRR | 426 | Q8N3U4 | |
| VLFLDRVYGIKDQTF | 2366 | Q15413 | |
| FAARGDYLQTLKFIQ | 161 | Q9BSA4 | |
| GKLVFFERRTFQRVY | 451 | Q9NW82 | |
| IEAIAKFDYVGRTAR | 731 | O75044 | |
| KFDYVGRTARELSFK | 736 | O75044 | |
| FFEGKELRLKQEYFV | 286 | P11216 | |
| LNYTRTLRFDDDKGF | 801 | P52849 | |
| LHSFYDRIKFLVGRD | 891 | Q6N022 | |
| KAFYSDVIAEDLRRG | 706 | P55017 | |
| FLRQRGTEIFEYSSK | 2196 | Q9P273 | |
| HIFFRDRYGTKQREL | 156 | A0A087X179 | |
| LRIFVYNEGLARFAT | 231 | Q8N841 | |
| KFEGAIYRKDVGFRA | 411 | P22102 | |
| IYRKDVGFRAIAFLQ | 416 | P22102 | |
| VAFHRGNFRELYKIL | 56 | Q9NPC8 | |
| GIRIKIADFGFARYL | 151 | Q8IYT8 | |
| YEFKLGKITFIRNSR | 261 | Q92890 | |
| IRYGIGFAKVFVDAR | 156 | O00755 | |
| LSFFEQFRKIYIGDQ | 551 | Q9UIA9 | |
| SDYGRAFIQKSDLFR | 331 | Q5JVG2 | |
| HIFFRDRYGTKQREL | 156 | A0A087WVF3 | |
| SSFRYEVLDLLGNRK | 751 | Q9UL62 | |
| KVETEYARFENGRFV | 336 | P28347 | |
| RYRLFSRFDDGIKLD | 651 | Q96RS0 | |
| FRETGQVLKLRYDSA | 231 | O14905 | |
| IEENENSGKFLRRYF | 16 | Q9HB21 | |
| NSGKFLRRYFILDTR | 21 | Q9HB21 | |
| KQRREIRAGTAFYID | 146 | A3KMH1 | |
| HIFFRDRYGTKQREL | 156 | Q8IZP1 | |
| FFEGKELRLKQEYFV | 286 | P06737 | |
| HIFFRDRYGTKQREL | 156 | A0A087X1G2 | |
| VFFRDRYGAKQRELF | 156 | P35125 | |
| ISALRFLGREKGYRF | 581 | Q9H267 | |
| HIFFRDRYGTKQREL | 156 | A0A087WXS9 | |
| HIFFRDRYGTKQREL | 156 | Q6IPX1 | |
| EYRLFFRCIRSKAEG | 71 | Q9UNY4 | |
| LRFEKGRIYTFIGEV | 31 | O94832 | |
| VRRAGFAFRQTYEKF | 621 | O94832 | |
| IFFRAGQVAYLEKLR | 746 | Q9ULV0 | |
| KLYENLGFVRDKRLF | 331 | Q147X3 | |
| SLVAAYGEAKRQRFL | 91 | P54296 | |
| ISLKDRERLLEGNFY | 1311 | Q12879 | |
| KEGLRDFYLDQFRTK | 1126 | Q13224 | |
| YERASKVDQFVTRFL | 131 | Q96P71 | |
| YRKLLEGEETRFSTF | 401 | P07197 |